Mammalian Models of Duchenne Muscular Dystrophy: An Investigation on the Neuromuscular Junction and Cardiac Functionality by Haddix, Seth Gregory
  
MAMMALIAN MODELS OF DUCHENNE MUSCULAR DYSTROPHY: AN 
INVESTIGATION ON THE NEUROMUSCULAR JUNCTION AND CARDIAC 
FUNCTIONALITY 
 
A Dissertation 
by 
SETH GREGORY HADDIX  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
Chair of Committee,  Mark Zoran 
Committee Members, Wesley J. Thompson 
 Joe N. Kornegay 
 Uel J. McMahan 
 Peter Nghiem 
 
Interdisciplinary  
Program Chair,  Michael Smotherman 
 
December 2019 
 
Major Subject: Neuroscience 
 
Copyright 2019 Seth Haddix
  
ii 
 
 ABSTRACT  
 
Duchenne muscular dystrophy (DMD) is muscle wasting disease that leads to early 
mortality in humans. It results from the absence of the protein dystrophin at the 
membrane, specifically the contractile cells of skeletal and heart muscle. Due to the lack 
of dystrophin, skeletal and cardiac myocytes have an increased susceptibility to 
contraction-related injury, bringing about cycles of degeneration and regeneration. With 
disease progression, regeneration fails and muscle is replaced by fibrotic and adipose 
tissue, which ultimately leads to muscle weakness. Investigations of skeletal muscle in 
DMD have generally ignored the neuromuscular junction (NMJ). The synapse is 
essential in proper skeletal muscle contraction. The NMJ in dystrophy is abnormal. The 
synapse forms non-continuous “islands” or fragments as compared to normal pretzel-like 
structures. Whether these fragmented NMJs are causative in disease progression has yet 
to be resolved and may represent a therapeutic target for disease amelioration. My 
studies extend understanding of DMD models by investigating the NMJ abnormalities in 
dystrophic mice and dogs, as well as cardiac muscle function in the former. 
The work in presented provides a comprehensive description of NMJ 
morphological features in mdx, a murine DMD model, and golden retriever muscular 
dystrophy (GRMD), a canine model. Using confocal microscopy, I compare the normal 
architecture and pathophysiology of diseased NMJs to normal. Junction structural 
changes are progressive with age in mdx, paralleling overall disease progression and 
severity and are similar to GRMD synapses. Using a technique that measures the 
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replacement of acetylcholine receptors (ACHRs) via their in vivo labeling, I show that 
receptor replacement is correlated with NMJ remodeling. I also report that dystrophic 
NMJ remodeling is initiated by muscle injury near the synaptic area. Isometric 
contraction force recording measurements of various muscles in geriatric mdx mice 
suggests that contractile function is unperturbed even in the face of synaptic remodeling. 
The cardiac function, as assessed by echocardiography and speckle tracking is 
dysfunctional in geriatric mdx hearts. I conclude that arresting NMJ remodeling caused 
by muscular dystrophy is not a viable therapeutic approach, but that the process is likely 
held in all mammals that lack dystrophin, including DMD boys.  
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NOMENCLATURE 
 
AChR Acetylcholine receptor  
AP Action potential 
DGC Dystrophin glycoprotein complex 
DI Dispersion index 
DMD Duchenne muscular dystrophy 
ECM Extracellular matrix 
EDL Extensor digitorum longus 
EF Ejection fraction 
EPP Endplate potential 
FS Fractional shortening  
GRMD Golden retriever muscular dystrophy 
mdx Murine X-chromosome linked muscular dystrophy  
MEPP Miniature endplate potential 
NMJ Neuromuscular junction 
P”number” Postnatal day “number” 
SOL Soleus 
STM Sternomastoid  
tSC Terminal Schwann cell 
UGC Utrophin glycoprotein complex 
WT Wild type 
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1. INTRODUCTION  
 
1.1. Duchenne muscular dystrophy and animal models 
The most common and extensively researched muscular dystrophy is Duchenne 
muscular dystrophy (DMD). The disease is X-linked, affecting about 1: 3,500 boys, and 
is caused by a genetic mutation in the DMD gene, which prevents the dystrophin protein 
expression from beneath the muscle sarcolemma where it is normally localized 
(Hoffman et al., 1987; Bonilla et al., 1988). Dystrophin is a large, 427 kDalton protein, 
that links the contractile apparatus of a muscle cell to the surrounding extracellular 
matrix (ECM) through a complex of proteins, called the dystrophin glycoprotein 
complex (DGC) or the dystrophin-associated protein complex. In myofibers, dystrophin 
binds to F-actin in the cytosol and b-dystroglycan, a muscle transmembrane protein. b-
dystroglycan, in turn, complexes with a-dystroglycan on the extracellular side of the 
myofiber. a-dystroglycan binds to other components of the ECM surrounding the 
myofiber, specifically laminins (Figure 1.1). Muscles that lack dystrophin fail to 
properly localize the components of the DGC to the muscle membrane, and 
consequently, the critical linkage between muscle fibers’ contractile apparatus and the 
ECM laminins is compromised. A milder disease, Becker’s muscular dystrophy, occurs 
due to in frame DMD gene mutations, allowing dystrophin to be expressed in a truncated 
form that is still semi-functional and able to connect components of the muscle cytosol 
to the sarcolemmal membrane and ECM.   
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Figure 1.1. The Dystrophin Glycoprotein Complex. 
Reprinted from (Rando, 2001). Dystrophin (dark blue) is located on the cytosolic side of 
the myofiber membrane, and links the contractile cytoskeletal machinery, through F-
actin (brown), to laminin proteins of the ECM (red), through beta and alpha-
dystroglycan (green). 
 
 
In dystrophic muscle diseases, the breakdown in cytoskeleton-to-ECM linkage 
leads to a loss of tensile strength at the muscle fiber surface which results in increased 
myofiber damage due to eccentric contraction (Moens et al., 1993). This myofiber 
damage causes a cycle of degenerative and regenerative events in the muscle fiber and a 
subsequently heightened inflammatory response. Boys affected by DMD eventually lose 
the regenerative ability provided to skeletal muscles by satellite cells, the resident stem 
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cells of skeletal muscle fibers. The impact of continued muscle necrosis, in the absence 
of satellite-derived regeneration, is the replacement of contractile muscle tissue with 
adipose and fibrotic tissue causing weakness, cardiorespiratory deficiencies, 
cardiomyopathy, and early mortality. Despite knowing the genetic cause of DMD for 
30+ years, there is still no cure for the disease and treatments are purely palliative 
(Emery and Muntoni, 2003).  
 There are many animal models for DMD ranging from Drosophila melanogaster 
to porcine, which vary in their similarity to DMD, and are thusly useful for 
understanding the disease in different ways. Two of the most commonly used models are 
the murine X chromosome-linked Muscular Dystrophy (mdx) mouse and the Golden 
Retriever Muscular Dystrophy (GRMD) dog. Like the human disease, both are X-linked 
and arise from spontaneous mutations in the DMD gene, although at different loci 
(Sicinski et al., 1989; Sharp et al., 1992). Both mutations are out-of-frame mutations 
resulting in a premature stop codon within the gene, and the full-length functional 
dystrophin protein is not produced. Additionally, both models show evidence of muscle 
fiber degeneration, but with differing severity.  
 
1.1.1. Mdx mouse model 
Although the majority of DMD related research has focused on the murine model, the 
mdx mouse has long been considered significantly limited in its usefulness. Early 
research into this line of mice indicated that damage to their muscles is much less severe, 
and they do not suffer from fibrotic and adipose tissue deposition until very advanced 
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ages. While the C57BL/10 (BL10) background is the most commonly used mouse 
model, it has been noted that genetic background does have an effect on disease 
progression. Dystrophic mice in a DBA/2 background were noted to display a more 
intense and earlier onset of disease state than those in a BL10 background (Coley et al., 
2015). The lifespan of mdx mice is truncated (Chamberlain et al., 2007), and the mice 
begin to display signs of dilated cardiomyopathy in adulthood starting at about 6 months 
of age (Van Erp et al., 2010), a phenomena noted in DMD as well. The muscles of mdx 
mice are said to suffer from an early life “crisis period” starting at about three post-natal 
weeks and stabilizing at about twelve weeks, after which the level of myofiber 
degeneration and regeneration decreases as shown in the tibialis anterior limb muscle 
(Dangain and Vrbova, 1984). Other limb muscles, such as the soleus (SOL) and extensor 
digitorum longus (EDL), show continued low levels of myofiber degeneration following 
the crisis period (Pastoret and Sebille, 1995). Whether all non-respiratory muscles 
undergo a crisis period in this model will be addressed further in this dissertation.   
It is evident that some dystrophic muscles are more prone to damage than others. 
For example, the extraocular muscles are largely spared from damaging incidents (Porter 
et al., 2003), while the diaphragm is highly affected and displays even earlier fibrotic 
tissue replacement than limb muscles (Stedman et al., 1991). The reasons for the sparing 
of some muscles and not others are not well understood, but are suggested to be the 
consequence of the frequency and rigor of muscle use (Edwards et al., 1984; Nguyen et 
al., 2002a). Sparing of the extraocular eyes has been suggested to be a result of the 
constitutive properties of the extraocular myofibers. These myofibers appear to be in a 
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developmentally immature state, which protects them from degenerative events (Porter 
et al., 2003). Functionally, mdx muscle does not suffer a decrease in general force 
production, and in fact may produce more force than its wildtype (WT) counterpart 
(Dangain and Vrbova, 1984). However, specific force is decreased and fatigability is 
increased in mdx muscles (Coulton et al., 1988b; Dellorusso et al., 2001; Chan et al., 
2007). Histological examination of mdx limb muscles shows that before 3 weeks of age 
muscle fibers of dystrophic animals are indistinguishable from WT animals. Thus, prior 
to the crisis period of the mdx model, limb muscles appear normal despite a lack of 
dystrophin expression. However, beginning at around postnatal day 21 (P21) sites of 
muscle necrosis and inflammatory cell (monocellular and neutrophil) infiltration are 
evident (Tanabe et al., 1986; Carnwath and Shotton, 1987). This is likely in response to 
ruptures found in muscle membranes, called delta lesions, which can be appreciated by 
viewing the accumulation of membrane impermeable dyes in dystrophic fibers. When 
ruptured, dye enters the muscle fiber, but is excluded from intact fibers with 
uncompromised membranes (Hamer et al., 2002). Following the onset of necrosis, foci 
of small, basophilic muscle fibers become more frequent. These fibers are regenerating 
muscle fibers. On the other hand, in the diaphragm muscle, replacement of muscle fibers 
with areas of endomysial fibrosis and adipose tissue replacement become increasingly 
evident with disease progression. This pathological event, however, is not appreciable in 
limb or trunk muscles until the end stages of the mouse disease at about 18 months of 
age (Chamberlain et al., 2007).  
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Dystrophic fibers follow a similar regenerative pathway to that of damaged WT 
muscles. Following necrosis and the infiltration of macrophages, satellite cells (resident 
stem cells of the musculature) become activated. Activation and proliferation of the 
satellite cells is initiated by cytokines eluted from macrophages following a switch from 
a pro-inflammatory to an anti-inflammatory state (Chazaud et al., 2009). Satellite cells 
then fuse forming a multinucleated syncytial cell, and begin to express myosin heavy 
chain (MHC) isoforms, part of the contractile machinery of a mature myofiber. Initially, 
neonatal and embryonic isoforms are expressed, which are indicative of newly 
regenerated fibers. As the myofibers mature they begin to express fast or slow MHC 
isoforms depending on their innervation by fast or slow type motor neurons (Ciciliot and 
Schiaffino, 2010). The activity of satellite cells following muscle injury is similar to how 
progenitor muscle cells behave during the developmental process, in that they activate, 
fuse into a single multinucleated cell (syncytial cell), mature, and express various time 
specific genes such as the MHCs. As mentioned before, muscles eventually lose their 
regenerative capacity as they age, and in DMD this is thought to likely be due to failures 
in satellite cell function; however, this may not be the case in mdx (Sacco et al., 2010; 
Boldrin et al., 2015). There is a theory that satellite cell exhaustion is dictated by 
telomere length. In mdx satellite cells, telomeres are not shortened as the animals age, 
and correspondingly there is no satellite cell exhaustion. However, when a telomerase 
enzyme that maintains telomer length is absent in mdx mice, muscles undergo a more 
progressive muscle wasting disease, ultimately due to satellite cell senescence (Sacco et 
al., 2010). 
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While changes to force generation are largely attributed to loss of contractile 
tissue, it is possible that some of the changes in behavior are due to changes in the 
peripheral synapse that controls muscle contraction, the neuromuscular junction (NMJ). 
This synapse has been noted to have changes to its structure in mdx mice (Lyons and 
Slater, 1991; Pratt et al., 2015a) and will be discussed further below. 
 Regardless of a perceived inability to mimic the human disease state, the mdx 
mouse model has been instrumental in investigating disease mechanisms and muscle 
regenerative processes, as well as helping to develop potential therapeutics such as exon 
skipping (Mann et al., 2001; Lu et al., 2003; Fletcher et al., 2007). Few of these 
techniques have translated into human patients, but there is significant research and 
excitement in the potential of CRISPR/Cas9 technology, a genetic editing technique, 
which has shown excellent efficacy in mdx mice (Xu et al., 2016; Bengtsson et al., 
2017), and is now being advanced in canine models of the disease (Amoasii et al., 2018). 
Additionally, gene replacement strategies, in which forced expression of truncated but 
functional forms of dystrophin are deliver to diseased muscle, also have the ability to 
restore functionally to skeletal muscles (Harper et al., 2002). Use of these truncated 
dystrophins has already been advanced into humans to treat DMD.  
 
1.1.2. GRMD dog model 
The GRMD model is appealing in that it more faithfully mimics the human disease. 
Affected dogs show appendicular muscle weakness as well as postural changes, both 
features in DMD boys. However, like mdx mice, the progression of the disease seems to 
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plateau in adulthood, but results in early mortality of affected animals. Unlike mdx mice, 
the GRMD model manifests itself at birth (Nguyen et al., 2002a), and the period of 
muscle instability is much longer (Valentine et al., 1986). Similar to both humans and 
mice lacking functional dystrophin, in GRMD small foci of necrotic muscle fibers and 
regenerating fibers are evident early in the disease state. Perhaps the most clearly 
identifiable histopathological feature in GRMD is large, rounded fibers, that occur either 
in small groups or as isolated muscle fibers. These have been termed hyaline or 
hypercontracted fibers and are considered a marker of muscle fiber necrosis. Hyaline 
fibers are evident from 4 months of age to 8 months of age, indicating, at least in this 
time period, that degeneration is ongoing. At early time points, pale areas are also 
evident and indicate empty basal lamina sheaths from which contractile tissue has been 
removed, some with invading monocellular cells. Surrounding these degenerating fibers 
are small regenerating muscle fibers. At later time points, these markers are still evident, 
but there is also an increased infiltration of inflammatory cells into the degenerating 
muscle, along with fibrotic tissue deposition (Valentine et al., 1986). These markers are 
hallmarks of DMD that are not as evident in the mdx model, especially fibrotic tissue 
deposition in the limb muscles. 
As in the murine model, specific muscles in GRMD animals respond to lack of 
dystrophin in distinct manners. Like mdx muscles, the extraocular muscles in GRMD are 
largely spared from injury and dystrophic pathology; however, muscles such as the 
tongue and diaphragm suffer from the events described above with varying severity. 
Interestingly, the cranial sartorius of GRMD animals is truly hypertrophied at 4-10 
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months, in that it becomes larger in volume and there is an early increase in contractile 
tissue and, only later, fibrotic and adipose tissue deposition (Kornegay et al., 2003). 
Muscle hypertrophy in GRMD is thought to contribute to joint contractures of the limb 
muscles, also a characteristic of human DMD. 
Like DMD patients and mdx mice, GRMD dogs display decrements in skeletal 
muscle force production (Kornegay et al., 1999). An intriguing trend is that flexor 
muscles are affected early in life, while extensors display decreases in force production 
later in life (Nguyen et al., 2002a). This is largely thought to be a consequence of the 
time course of muscle usage during development. Flexor muscles are used for the 
crawling behaviors of puppies. As dogs mature, they must support more body weight 
and extensor muscles become activated. As the muscles contract, they incur damage due 
to dystrophin loss and associated membrane instability, which leads to decreases in 
maximal force production. Membrane injury and force reduction becomes especially 
evident when GRMD muscles are subjected to eccentric contractions (Tegeler et al., 
2010). In addition, NMJ morphology of GRMD animals is also abnormal when 
compared to WT controls, similar to that seen in mdx (Haddix et al., 2018). Whether 
NMJ changes in GRMD specifically have an effect on muscle function has not been 
studied. 
 
1.2. Structure and function of the neuromuscular junction 
The NMJ is the site of communication between the peripheral nervous system and 
skeletal muscles. Its purpose is to transmit neural signals to muscle fibers, thereby 
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initiating body movements. The synapse is tripartite. It consists of the postsynaptic 
acetylcholine receptor (AChR) aggregate on the surface of muscle fibers, the presynaptic 
terminal branches of motor axons, and terminal Schwann cells (tSC) that interact with 
pre- and postsynaptic cells (Sanes and Lichtman, 1999). The neuromuscular synapse has 
a highly reliable physiology and a distinct morphological structure that compliments its 
function.  
 The mammalian NMJ has been studied extensively in rodents and, as such, much 
is known about its morphology and development. The excitatory neurotransmitter of 
mammals released from motor neurons on to skeletal muscle fibers is acetylcholine. 
Tens of thousands of single AChRs are clustered upon the muscle fiber surface in mature 
NMJs in a specific area of close apposition to the nerve terminal, called the endplate. 
The role of the endplate is to detect and respond to neurotransmitter release. The 
microscopic morphology of the endplate’s AChR aggregate is described as “pretzel-like” 
(Figure. 1.2A). Long, continuous ribbons of AChR are aggregated in the muscle fiber 
plasma membrane, or sarcolemma, and are ultimately responsible for receiving signals 
from the motor axon and converting them into electrical changes across the muscle 
membrane, which in turn result in muscle contraction. The motor axon terminal resides 
directly above the aggregation of receptors, in a branching pattern that closely follows 
that of the pretzel itself (Figure 1.2B). This nerve terminal-end plate connection is 
maintained by bindings to the synaptic ECM, by both muscle and neuron, through 
laminins, fibronectin, and other ECM components (Sanes et al., 1986; Chipman et al., 
2010). The receptors themselves are heteromeric structures consisting of five subunits 
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that compose a cation channel containing binding sites for acetylcholine (Popot and 
Changeux, 1984). Activation of the AChRs by the binding of acetylcholine molecules 
results in the receptor channel opening, depolarization of the sarcolemma and, 
ultimately, excitation-contraction coupling (Catterall, 1991).  
 
 
 
Figure 1.2. The structure of a mature NMJ. 
Maximum projection confocal micrographs. Canine tissue. A) AChRs are arranged in a 
continuous pretzel-like morphology on the surface of the muscle fiber. B) The motor 
axon run along the ribbons of the receptor aggregate, while C) the tSCs cover and cap 
the structure. D) Composite. Red = AChR. Cyan = Axon. Green = tSC. Scale bar = 20 
µm. 
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Electron microscopic techniques have been used to detail the NMJ ultrastructure. 
These investigations revealed that in mature NMJs, the motor axon rests within a minor 
indentation upon the muscle fiber, called a gutter. Under the axon, the muscle membrane 
further projects inward forming so called junctional folds. At the crests of the folds, 
directly apposing vesicle fusion sites in the axon terminals, AChRs are deposited 
(Salpeter and Harris, 1983). In the bottoms of the folds, there is an accumulation of 
voltage-gated sodium channels that are responsible for eliciting action potentials (APs) 
in the muscle, as well as components of the DGC (Sanes and Lichtman, 1999). When 
labeled using immunohistochemistry, dystrophin can be seen to localize to both the 
sarcolemma and the NMJ (Figure 1.3). At the crest of the folds a homolog to dystrophin, 
utrophin, recruits largely the same proteins as that of the DGC, but is intimately involved 
in the development of the NMJ. The utrophin glycoprotein complex (UGC), is 
concentrated in muscle at the endplate and the myotendinous junction and also provides 
a linkage from muscle fiber to ECM (Khurana et al., 1991).  
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Figure 1.3. Dystrophin is highly expressed at the NMJ. 
Reprinted from (Pratt et al., 2015a). WT mice express dystrophin both at the NMJ, 
labeled via a-bungarotoxin (BTX), and below the sarcolemma. Mdx animals do not 
express dystrophin at either location. Note the continuous nature of the WT AChR 
aggregate and the fragmented nature of the mdx. Colocalization of BTX (green) and 
dystrophin (red) is pseudocolored yellow. Scale bar = 10 µm. 
 
Capping the NMJ endplate structure are the non-myelinating tSCs (Figure 1.2C), 
which provide trophic support and maintenance to the synapse (Reddy et al., 2003; Feng 
and Ko, 2008b; Feng and Ko, 2008a). In rodents, there are typically 3-5 tSCs associated 
with each NMJ. The somata of the tSCs lie along the motor terminal, while the small 
processes of tSCs extend to cover the axon branches. As tSCs do not create myelin 
sheaths they have no role in saltatory conduction. They are, however, able to respond to 
purinergic and muscarinic signaling from the motor neuron, and may play a role in 
determining neurotransmission efficiency (Georgiou et al., 1999; Rousse and Robitaille, 
2006). 
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Although neuromuscular synapses are often referred to as tripartite in nature, a fourth 
aspect of the NMJ should be noted, the synaptic basal lamina. This is a composite of 
signaling and structural components that reside in the synaptic cleft, the small gap 
between the pre- and postsynaptic cells. This cleft is densely filled with extracellular 
matrix, including collagen, laminin and agrin, and is critical for NMJ development and 
function (Slater, 1990). In healthy synapses, the synaptic cleft is a 50 nm gap that can be 
viewed with transmission electron microscopy (TEM) following osmium tetroxide 
precipitation (Smith et al., 2013). This synaptic cleft’s electron density is generated by 
the protein components of the ECM and DGC, which keeps the synapse from becoming 
displaced following muscle contraction or damage to the NMJ (Betz and Sakmann, 
1973).  
Also present in the synaptic cleft is an enzyme acetylcholine esterase (AChE) 
derived from the muscle cells and tethered to the ECM. AChE is responsible for 
hydrolyzing acetylcholine into its constitutive parts, choline and acetate, to allow the 
neurotransmitter byproducts to be recycled back into the neuron. Hydrolyzation of the 
neurotransmitter prevents both receptor desensitization and neurotoxicity. The enzyme 
also localizes at the endplate region of the muscle in the same morphology as the AChR 
cluster (Brimijoin, 1983). Taken together, the NMJ synaptic cleft and its associated 
ECM, DGC, enzymes, signaling molecules and scaffolds constitute an essential and 
often overlooked player in the structure and function of this synapse. The NMJ cleft’s 
necessity in skeletal muscle function and its role in diseases such as DMD may require a 
more modern view of NMJ as a quadripartite synapse. 
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Within an animal group, or even a genus, NMJ morphology can be vastly 
different. In an invertebrate (Drosophila) system, the variance in fly NMJ morphology is 
striking and cannot be explained by genetic drift, nor body size of the insect (Campbell 
and Ganetzky, 2012). Importantly, the shape of the presynaptic terminus in flies does not 
have an effect on neuromuscular performance. Neither the frequency or the amplitude of 
MEJPs (miniature excitatory junctional potentials), nor excitatory junctional potentials 
amplitudes were different among species of Drosophila. Still, the motor axon terminals 
and NMJ morphology, which resemble beads on a string, differed significantly. 
Therefore, the form of the NMJ does not necessarily dictate its overall synaptic function.  
In some vertebrates, such as the frog for example, motor nerve terminals have long 
continuous protrusions that extend laterally across the myofiber. Even between 
mammals there are distinct differences in the terminal structure of the NMJ. Rodents, as 
mentioned before, the terminal branches into ribbon a like structure within the defined 
pretzel structure of the endplate. In humans, the terminal is smaller and made up of small 
bulbous varicosities along thinner axonal ribbons (Slater, 2008; Jones et al., 2017). 
Postsynaptic accumulation of receptor (glutamate receptors for flies, AChR for 
vertebrates) mirrors that of the presynaptic morphology. Between rodent and humans, 
this translates as the difference between a continuous receptor aggregate and a more 
fragmented morphology, respectively. Junctional fold length and number beneath the 
nerve terminal are also different between species. Frogs have relatively few, short 
invaginations, while humans have many, longer ones. There is an inverse relationship 
between the complexity of postsynaptic folding and the size of the endplate. These 
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changes manifest themselves functionally as well. The amount of acetylcholine released 
by the axon terminal is typically much more than is necessary to bring a muscle fiber to 
threshold and induce a muscle contraction. This overabundance of acetylcholine release 
is termed the safety factor, and plays a role in maintaining synaptic function over a wide 
array of physiological conditions (Wood and Slater, 2001). Postsynaptic folding of the 
muscle membrane is thought to play a role in determining the safety factor. The folds 
create a path of increased resistance to the voltage gated sodium channels that are 
clustered at the depths of the folds, essentially channeling depolarizing current to these 
channels (Martin, 1994). In theory, endplates with longer postsynaptic folds should have 
increased resistance and therefore a higher safety factor. This may not be the whole 
story, however, as muscles with similar folding morphologies can display different 
safety factors (Wood and Slater, 1997). 
 The conservation of synaptic function, even among vastly different NMJ 
morphologies, is of particular interest in neuromuscular disease. As mentioned above, 
the morphology and structure of dystrophic NMJs is distinct from that of non-diseased 
synapses. The question then arises in light of the fact that synaptic function is not much 
perturbed between species with different NMJ morphologies— are the changes noted in 
DMD models due to homeostatic adaptations to preserve synaptic integrity? 
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1.3. Development and maintenance of the neuromuscular junction 
While in adulthood the synaptic structure is quite static, the NMJ goes through distinct 
changes in morphology during development. At buirth birth (P0) in rodents the AChR 
are clustered into a “plaque”. Axons terminals of many motor neurons as situated just 
opposite it. By postnatal day 14 (P14), the AChR aggregate has matured into its pretzel-
like morphology, progressing through distinct intermediates as its structure changes over 
time (Marques et al., 2000). This rearrangement of postsynaptic structure is coincident 
with synapse elimination via the withdrawal of the terminals of motor axons, until the 
terminals of only one axon remain per endplate. Nonetheless, most motor neurons 
innervate multiple muscle fibers, which allows all connected muscle fibers to contract as 
a collective. A single motor neuron and the many muscle fibers it innervates have been 
termed a motor unit. All muscle fibers that make up a single motor unit are noted to have 
the same myofiber subtype (I, IIa, IIb, etc.), and it has been determined that the motor 
neuron dictates these myofibers’ contractile and metabolic properties (Buller et al., 1960; 
Stålberg, 2004).   
The cues for maturation of the postsynaptic apparatus to the pretzel shape come 
from all aspects of the NMJ (muscle, neuron, tSC, and basal lamina). Activity of the 
presynaptic neuron (Balice-Gordon and Lichtman, 1994; Busetto et al., 2000), as well as 
stresses imposed by phagocytic tSCs, drive synapse elimination (Smith et al., 2013). 
Additionally, there are factors secreted from the motor axon into the synaptic cleft that 
are known to promote synaptic maturation. One of these factors, neural agrin, is directly 
involved in the clustering of AChR aggregate (McMahan, 1990). Agrin binds to a low-
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density lipoprotein receptor-related protein 4 (LRP4) which in turn causes 
transphosphorylation of muscle-specific kinase (MuSK). The MuSK/LRP4 complex is 
tethered to the sarcolemma and extends into the synaptic cleft (Kim et al., 2008). MuSK 
activation results in AChR clustering is contingent upon LRP4 biding to agrin (Zong et 
al., 2012). MuSK expression is implicated not only in the physical aggregation of 
AChRs but also with the elevated synaptic transcription of AChR subunits (Jones et al., 
1999; Yang et al., 2001). An adapter protein, downstream of tyrosine kinase (Dok7), acts 
as an enhancer proteins for MuSK phosphorylation and the activation of receptor 
clustering activity (Okada et al., 2006). Downstream of the agrin/MuSK/LRP4 complex 
is Rapsyn, which binds AChRs and is also necessary for clustering (Apel et al., 1997; 
Moransard et al., 2003). AChR expression, however, is not contingent on Rapsyn 
(Gautam et al., 1995). The MuSK/LRP4 complex may also have a role in the 
development, and specialization, of the presynaptic apparatus. In cell culture 
experiments, it was determined that LRP4 acts as a retrograde signal to motor terminals 
directing the formation of active zones, release sites at areas of apposition to AChRs 
(Yumoto et al., 2012).  
Agrin surely acts as AChR clustering and postsynaptic maturation signal secreted 
from the motor neuron, but there is evidence that clustering can occur without 
innervation, and therefore in the absence of neural agrin. The developmental clustering 
of AChRs before the motor neuron innervates them has been termed pre-patterning. 
Muscle derived agrin is not responsible for this phenomenon, as it lacks portions of the 
protein that result in clustering ability through MuSK/LRP4 binding (Ruegg et al., 1992; 
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Ferns et al., 1993). The maturation of secondary myotubes may provide an explanation. 
Secondary myotubes form near the center of the developing muscle and express high 
levels of AChR subunit transcripts (Yang et al., 2001) as well as a number of 
transcription factors. Myogenin is one such factor involved in muscle maturation 
(Babiuk et al., 2003), and also AChR subunit expression. It should be noted however 
that myogenin’s effects on AChRs is dependent on electrical activity in the myotube 
(Dutton et al., 1993). Increased receptor expression at this central area, due to the high 
concentration of muscle precursor cells, could give rise to the pre-patterned clusters. 
Additionally, MuSK expression is elevated in the secondary myotubes at the central 
band region (Kim and Burden, 2008). Forced self-activation of MuSK through 
dimerization not only causes the clustering of receptors but also increased expression of 
the subunit transcripts, and may be involved in pre-patterning (Jones et al., 1999; Yang 
et al., 2001). As the nerve contacts the muscle and the central band region, agrin is 
released, resulting in further clustering and stabilization of the post-synaptic apparatus. 
In fact, the agrin/MusK/LRP4 complex may act as a stop signal for axon growth. The 
nerves of agrin knockouts grow well past the pre-patterned clusters along the muscle 
fibers (Campagna et al., 1995; Gautam et al., 1996).  
Interestingly acetylcholine release plays a role in AChR clustering at the endplate 
site. In the absence of acetylcholine release or agrin, NMJs form normally and in fact the 
number and size of innervated clusters increases (Misgeld et al., 2005). Additionally, 
acetylcholine agonists have the ability to cause endocytosis of AChR in cell culture 
when agrin is not present (Misgeld et al., 2005). 
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Regardless of whether the cues for synaptic maturation are derived from 
primarily the neuron or the muscle (as suggested by pre-patterning), if key members of 
the signaling complex are missing NMJs do not form or form abnormally (e.g. agrin, 
MuSK, LRP4, Dok7, or Rapsyn). 
In dystrophy, there is evidence that the development of the NMJ, from the plaque 
morphology to the mature pretzel, is accelerated (Minatel et al., 2003). Not only is 
postsynaptic maturation altered, the synapse reaches a single innervated state earlier than 
WT animals. There is perhaps a role in dystrophy in the initial development of the NMJ, 
and it is certainly implicated in rearrangement of the mature endplate structure following 
muscle fiber injury caused by its loss. 
 
1.4. Neuromuscular regeneration  
Unlike the central nervous system, the mammalian peripheral nervous system has potent 
capacities for regeneration following injury. As mentioned above, the regeneration of 
damaged muscle cells is contingent upon satellite cell activation, fusion, and maturation 
into viable myofibers. Following muscle fiber ablation in the frog, the nerve terminal 
remains at the synaptic location, even in the absence of the postsynaptic muscle fiber 
(Yao, 1988; Dunaevsky and Connor, 1995, 1998). During the regenerative process of the 
muscle, a new NMJ is formed in the same area as the old with receptor deposited under 
the motor terminal (Burden et al., 1979). Even if both muscle and nerve are damaged, 
following the regeneration of both cells, a synapse at the location of the old is 
reconstituted (Marshall et al., 1977).  
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Motor neuron terminals act differently in the rodent model. Following muscle 
fiber necrosis, the motor neuron follows one of two paths. Either the motor neuron 
remains at the synaptic site, likely tethered to the basal lamina, or the terminal retracts 
from the synaptic site. This difference in response may be explained by the severity and 
type of damage incurred by the muscle fiber. Following muscle crush near the synaptic 
area, the nerve terminal retracts from the synapse following muscle fiber necrosis (Rich 
and Lichtman, 1989a). It should be noted that while the experimental procedure used to 
care not to damage the nerve, there was no way to fully guarantee it wasn’t also crushed 
with the muscle. If damaged the nerve would retract from the muscle fiber skewing 
results. Following myofiber ablation via focal laser ablation, the nerve terminal remains 
during the subsequent regenerative process (Li and Thompson, 2011). Regeneration of 
the muscle also results in the establishment of a new NMJ, at the site of the previous 
synapse. In some cases, the morphology of the postsynaptic apparatus changes little, if 
any, upon successful reestablishment of the contact between muscle and nerve. In other 
cases, small branches are added to the regenerated synapse, while in other cases such as 
those associated with DMD and other diseases, a vast morphological change is evident. 
The structural reorganization of the postsynaptic apparatus seen in damaged and 
dystrophic synapses is part of a phenomenon called NMJ remodeling, which will be 
defined in further detail in subsequent sections of this dissertation.  
 The axon of the lower motor neuron also has a great capacity for regeneration. If 
injured, the motor terminal degrades below the site of injury and the proximal stump 
retracts. After some time, depending on the degree of injury and the distance from the 
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muscle, an axon (originating from either the initial neuron that connected to the muscle 
fiber or a foreign neuron) regrows from a proximal stump using the endoneurial tube and 
Schwann cells to the muscle fiber. This axon makes contact at the extant synaptic site on 
the muscle and extends branches into the gutters of the receptor aggregate (Rich and 
Lichtman, 1989b; Nguyen et al., 2002b).  
Contingent on this regenerative capacity of motor neurons is the activity of 
Schwann cells, both myelinating and non-myelinating. Schwann cells, the 
multifunctional glia of the periphery, are responsible for the myelination of the axons of 
alpha motor neurons and therefore responsible for saltatory conduction. Upon insult to 
the peripheral nervous system the Schwann cells provide two distinct roles. A population 
of the glia adopt phagocytic characteristics and begin to digest cellular debris associated 
with axonal degeneration, namely myelin and axonal cellular components (Kang and 
Lichtman, 2013). The Schwann cells also provide the track that the regenerating motor 
neurons will use to reinnervate muscles. During the degeneration process the Schwann 
cells and the surrounding endoneurium remain in place. They create Bands of Büngner 
that act as a bridge for the growing axon to navigate the injury site on the muscle fiber to 
the NMJ (Arthur-Farraj et al., 2012). As the neuron reaches the endplate, branches of the 
terminal re-enter the gutter of the postsynaptic apparatus without morphological 
rearrangement of the synapse.  
During partial denervation, such as that created by crushing only a section of a 
nerve, newly denervated NMJs may be adjacent to neighboring muscle fibers with 
innervated NMJs. As the nerve terminal is removed following damage, tSCs will extend 
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processes from the denervated endplate in a seemingly stochastic manner. If a process 
grows to an innervated endplate, then the terminal Schwann cell can provide a bridge 
upon which the axon sprouts from the innervated NMJ can grow. Ultimately, the axon 
can reinnervate the denervated junction, growing into the gutters that the previous axon 
occupied (Son and Thompson, 1995). This reinnervation process, in turn, changes the 
muscle fibers that are part of that motor unit. It is possible that the reinnervated muscle 
fiber’s contractile properties, based on the isoform of MHC expressed, may also change 
if the new neuron is of a different type (fast or slow) than the old. In mdx mice it is quite 
evident that there are changes to the pre- and postsynaptic structure, likely caused by 
myofiber damage. 
 
1.5. Neuromuscular junction remodeling  
It is well established that as animals age the morphology of the NMJ changes as well. 
This is a normal and necessary maturation that relies upon both pre- and postsynaptic 
factors. While the adult NMJ morphology is very stable, there is irrefutable evidence that 
NMJ remodeling can occur in certain instances. Some of the best-recognized examples 
are in advanced age, muscle injury, and diseases such as DMD.  
 In aging, the postsynaptic apparatus has a clear morphological shift from a 
continuous pretzel to a more fragmented appearance (Li et al., 2011). Additionally, in 
extremely advanced age there is a granularization of the receptor aggregate (Valdez et 
al., 2010). At these geriatric ages, there is also evidence of motor axon die back, where 
the motor terminal vacates the endplate area. Axonal die-back causes tSCs from adjacent 
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endplates to sprout to the denervated endplate. Axons from innervated endplates then 
grow along these tSC tracks to re-innervate the recently vacated endplate as in peripheral 
nervous system damage (Connor et al., 2002). The concepts of NMJ remodeling and 
endplate fragmentation, in combination with NMJ age, are central to the current 
dissertation research.  
Vital imaging experiments demonstrate that fragmentation of AChR aggregates 
can be initiated by muscle fiber degeneration and regeneration. Indeed, when a single 
muscle fiber is damaged with a high intensity laser near the endplate area, a once 
continuous AChR aggregate is transformed into a fragmented one (Li and Thompson, 
2011). It is possible that similar processes are taking place in aging myofibers, as aged 
muscles are more susceptible to injury. The same phenomenon has been suggested for 
muscular dystrophies (Lyons and Slater, 1991). Just as seen in aging and muscle damage 
experiments, dystrophic NMJs are clearly abnormal. AChR aggregates are fragmented 
from an early age in dystrophic mice. There is also a coincident change in the 
morphology of the innervating motor neuron and a proliferation of tSCs in mdx mice 
(Pratt et al., 2015a). However, there is little evidence of ultra-terminal (originating from 
the endplate) axon sprouting to adjacent endplates suggesting little to no denervation in 
these animals, at least in early adulthood (Lyons and Slater, 1991). The NMJ remodeling 
process in the context of dystrophy will be elaborated on in Sections 2, 3, and 4 of this 
report.  
It is likely that the regeneration process of the muscle also causes a 
rearrangement of the synaptic basal lamina, which would have a role in the remodeling 
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process of NMJs. Basal lamina changes are suggested by a widening of the synaptic cleft 
and the loss of secondary fold under some terminals in muscular dystrophy (Law et al., 
1983; Lyons and Slater, 1991). The increased width of the synaptic cleft is suggested to 
be a result of ECM elution from the regenerating muscle fiber, which is added to the 
existing ECM retained during myofiber necrosis. The continued build-up of ECM could 
not only widen the cleft but also flatten ECM projections at the endplate. So upon full 
regeneration secondary folds would be lost. Agrin, which is tethered to the basal lamina, 
distribution may then be altered following ECM build up. Subsequent reconstitution of 
the NMJ could be affected as the myofiber expands and touches only some areas of agrin 
deposition. Alternatively, agrin that initially provided a clustering signal may not ever 
bind to the newly expressed MuSK/LRP4 complex on the regenerated myofiber. The 
new ECM could mask binding epitopes of the receptors. In this case newly released 
agrin from the rearranged motor terminal could instruct NMJ remodeling. A 
distributional change of these signaling molecules has not been investigated, but there is 
evidence of changes to the basal lamina in muscle fiber regeneration (Gulati et al., 1983) 
and dystrophy (Patton et al., 1999). 
There is, however, evidence of NMJ remodeling even in the absence of myofiber 
necrosis and regeneration. TSC activity itself seems able to remodel junctions. When the 
activity of tSCs is elevated via motor neuron overexpression of Type III NRG1, receptor 
aggregates become fragmented in appearance (il Lee et al., 2016). In fact, the AChR 
morphology is indistinguishable from muscle injury models. It is evident that this 
remodeling is independent of myofiber necrosis and regeneration. A hallmark sign of 
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myofiber regeneration is the appearance of nuclei running through the center of a 
myofiber, sometimes in small segments and sometimes in long chains (Figure 1.4). In 
uninjured, mature muscles, myonuclei run in a spiral around the periphery of the 
syncytia directly under the sarcolemma (Bruusgaard et al., 2003). When myofibers 
regenerate their nuclei localize to the center of the cell and remain there for up to 6 
months (Wada et al., 2008).  
 
 
 
Figure 1.4. Examples of peripheral and central myonuclei. 
Reprinted from (Terada et al., 2010). Isolated muscle fibers from WT and mdx labeled 
with propidium iodide. Mdx myofibers display both central (left most panel) and 
peripheral nuclei, while WT myonuclear distribution is predominantly peripheral.  
 
 
When tSC activity is increased genetically, there is no evidence of central nuclei 
in myofibers. So, it is likely that the fibers remain intact and that it is purely presynaptic 
influence that remodels the junction. Whether tSCs play a role in remodeling NMJs in 
damaged muscle fibers remains to be investigated.  
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1.6. Physiology of remodeled NMJs 
It is evident that aging, disease, and muscle damage all have a role in NMJ remodeling 
from a continuous, pretzel morphology to an aberrant, fragmented morphology. 
However, the consequence of this change in appearance on the function of the synapse is 
a contested subject in the field. Aged, fragmented junctions are equally as efficient at 
neuromuscular transmission as middle-aged ones (Willadt et al., 2016). It must be noted 
that although this experimental protocol did not investigate specifically remodeled 
NMJs, the ages of mice examined make it likely that most synapses were abnormal in 
their morphology.  
Muscles damaged by eccentric contractions have also been shown to have force 
deficits following lengthening. While this has traditionally been hypothesized to occur as 
a result of breaking the cross-bridge connections between the actin and myosin filaments 
in sarcomeres, or potentially excitation-contraction uncoupling at t-tubules, there may 
also be a deficit in neuromuscular transmission (Warren et al., 1999; Deschenes et al., 
2000).  
The effects of NMJ remodeling in disease, specifically DMD, is also unclear. 
Analysis of NMJ performance in mdx animals, where it is known the NMJ is abnormal, 
is sparse. However, there is evidence of slight changes in neuromuscular transmission in 
the mdx model. A finding corroborated on human studies is a depressed mean resting 
potential of dystrophic muscle fibers (Carlson and Roshek, 2001). This is possibly due to 
changes in ion channel properties, or membrane permeability to sodium and calcium, 
both of which could compromise NMJ transmission. Additionally, it has been reported 
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that mdx mice display changes in miniature endplate potential (MEPP) characteristics, 
features associated with altered spontaneous synaptic transmission, or AChR properties. 
Notably MEPP amplitude is smaller and more variable than WT animals, but MEPP 
frequency is unaltered (Nagel et al., 1990; Carlson and Roshek, 2001; van der Pijl et al., 
2016). This does not, however, seem to correspond with changes in action potential-
evoked endplate potential (EPP) amplitude (van der Pijl et al., 2016). Interestingly, there 
may be changes to the receptor density (Nagel et al., 1990), but this finding is contested 
(Lyons and Slater, 1991). Other studies have recorded variability in twitch force in 
nerve-stimulated muscle responses (Personius and Sawyer, 2006), which might stem 
from the muscles varied ability to respond to acetylcholine. It is unlikely that dystrophic 
muscle fibers’ variable responses to nerve stimulation has much or any pathological 
effect, and overall loss of contraction force is due more in part to myofiber degeneration. 
Neuromuscular transmission deficits may play a role in dystrophic muscles increased 
fatigability during tetanic stimulation, as EPP values fall with repetitive stimulation (van 
der Pijl et al., 2016).  
When neuromuscular performance is assessed in GRMD dogs, some notable 
differences can be found compared to WT. These affected dogs also have abnormal 
NMJs, as noted in their mdx counterparts which will be discussed in Section 2. 
Specifically, using single fiber EMG, both GRMD dogs and DMD boys show increased 
jitter and fiber density (Kornegay et al., 2012). Jitter in single fiber EMG indicates a 
variation in muscle fibers of the same motor unit generating action potentials in 
comparison to other muscle fibers in the motor units. In normal systems, muscle fibers 
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within the same motor unit will activate with a clearly defined (but very short) time 
interval between them (Figure 1.5a). In some cases, however, the delay between action 
potential generation is increasingly variable, as is seen in dystrophic and myasthenic 
muscle (Figure 1.5b). In fact, sometimes complete failure to activate the myofiber is 
noted in a phenomenon called blocking (Figure 1.5c).  
 
 
 
Figure 1.5. Single fiber EMG jitter recordings. 
Reprinted from (Selvan, 2011). Variation in the timing of muscle fiber activation within 
the same motor unit is defined as jitter, and indicative of changes to neuromuscular 
transmission. Low jitter indicates reliable neuromuscular transmission, while increased 
jitter or blocking indicates discrepancies or failures. a) Normal jitter. b) Increased jitter. 
c) Increased jitter with blocking as seen in second and fourth traces from top. Above 
traces are from myasthenic muscle but increased jitter is noted in DMD and GRMD 
muscle.  
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The increased fiber density, or the recording of multiple APs via single fiber 
EMG, is indicative of regenerating myofibers in the vicinity of the recording electrode 
probe. However, it is likely that these slight differences in neuromuscular transmission 
are not responsible for the drops in force noted in GRMD muscles. More probable is 
that, as in mdx mice, specific force drops seen in dystrophic dogs result from myofiber 
injury and in the case of dystrophic dogs, replacement of contractile tissue with fibrotic 
and adipose tissue.  
 
1.7. Dystrophic cardiomyopathy 
Advances in respiratory therapy have significantly lengthened the lifespan of DMD 
patients, extending life into their third or fourth decade. However, with these important 
life extensions come concomitant complications in cardiac function and additional 
contributing factors in disease pathology. Indeed, dilated cardiomyopathy accounts for 
20-30% of DMD mortalities as treatment has ameliorated respiratory complications that 
accounted for earlier mortality (Eagle et al., 2002; Passamano et al., 2012).  
 Dystrophic cardiac involvement begins early in life, but does not manifest 
clinically until later years (Figure 1.6). Lack of dystrophin in the cardiomyocytes is also 
the cause of this heart dysfunction and has similar myofiber impacts as dystrophin loss 
from skeletal muscle. That is to say, decreased cellular membrane integrity leads to 
increased damage of the heart cells (Danialou et al., 2001), inflammatory cell infiltration 
into cardiac tissue (Mavrogeni et al., 2010), and gradual and progressive fibrosis of the 
heart (Frankel and Rosser, 1976). These disease processes result in decreased cardiac 
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function due to diminished contractile tissue, but unlike skeletal muscle, the heart does 
not have resident stem cells for tissue regeneration.  
 
 
Figure 1.6. Dilated cardiomyopathy associated with muscular dystrophy. 
Adapted from (Bostick et al., 2008). Cross section of left and right ventricle of mouse 
heart. Masson trichome stain in blue indicates connective tissue, while alizarin red 
labeling shows calcium deposition. Note the increase in connective tissue and calcified 
areas of the mdx heart at 21 months. The left ventricle also becomes dilated in 
comparison to the BL10 heart, indicating dilated cardio myopathy.  
 
 
The standard diagnostic technique for cardiomyopathies is echocardiography and 
cardiac MRI (Buddhe et al., 2016). Decreases in ejection fraction and fractional 
shortening, measurements of the contractility of the left ventricle, are indicative of 
decreased cardiac function in DMD. Additionally, more advanced methods of 
echocardiography, such as speckle tracking or Doppler tissue imaging (techniques that 
measure the elasticity of the myocardium), are more sensitive to changes and contrasts 
between a DMD and normal heart, and can predict the development of clinical 
cardiomyopathy before patients present overt symptoms (Ogata et al., 2007).  
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Dystrophic dogs also display an advancing cardiomyopathy associated with 
dystrophin loss (Valentine et al., 1989; Moise et al., 1991; Fine et al., 2011; Guo et al., 
2019). When conscious echocardiography is used as a diagnostic, systolic function is 
significantly decreased in older, affected dogs as compared to younger ones. Like DMD 
boys, using speckle tracking and evaluating myocardial strain decreases has been shown 
to be a sensitive strategy to predict the development of dilated cardiomyopathy in 
affected dogs (Guo et al., 2019). 
The mdx mouse model presents similar dilated cardiomyopathies and decreased 
left ventricular function. These dystrophic mice also have a reduced life span, but the 
cause has not been attributed to cardiac malfunction. Few echocardiographic studies 
have investigated the progression of cardiac involvement at near-death time points (i.e. 
+18 months), with most ending at 12 months. In these cases, fibrosis is increased and 
strain analysis via speckle tracking reveals cardiac dysfunction (Spurney et al., 2011). 
The severity of cardiomyopathy in mdx mice has been investigated and discussed in this 
research project. 
 
1.8. Research focus 
While DMD is a vastly researched disease, there is comparatively minimal investigation 
in to how the synapse is responsible for voluntary motion or how the NMJ develops, 
functions, and degrades in dystrophic disease. While it is generally agreed upon that the 
NMJ remodels due to myofiber degeneration and regeneration at the endplate region, 
direct evidence for this phenomenon in muscular dystrophy is scarce. In the forthcoming 
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chapters, a more accurate description of the NMJ remodeling process due to muscular 
dystrophy in mouse and dog models is given. Focus is also centered on the function of 
these remodeled synapses. I find, in agreement with the majority of literature, that 
remodeling of the NMJ does occur in this mdx model, and that it is due to myofiber 
damage at the endplate site and under direct control of the innervating motor axon. In 
addition, I provide an updated view of the mdx mouse’s value as a model of DMD, and 
give evidence that remodeling of the NMJ is a shared attribute of mammals lacking the 
dystrophin protein. I report on the efficiency of neuromuscular transmission in muscular 
dystrophy and the potential role of receptor aggregate fragmentation. Finally, a brief 
investigation of cardiomyopathies in mdx mice is described. 
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2. MORPHOLOGICAL ABNORMALITIES OF THE DYSTROPHIC NMJ1 
 
2.1. Research impetus 
As mentioned in Section 1, there is a repertoire of evidence that dystrophic NMJs are 
abnormal in appearance (Lyons and Slater, 1991; Minatel et al., 2003; Pratt et al., 
2015a). Much attention has been given to the postsynaptic AChR aggregate, which has 
been described as fragmented into non-continuous clusters of receptors, as compared to 
the continuous pretzel formation of healthy synapses. Aside from the fragmentation, 
other noticeable changes to dystrophic NMJs have been reported including 
morphological changes to the presynaptic components. Using an mdx mouse model that 
expresses fluorescent proteins in both the motor axon and Schwann cells, I sought to 
make rigorous measurements and analyze the pre- and postsynaptic structure of NMJs in 
mdx mice, including the innervating motor axon and tSCs, and to describe how the 
synaptic rearrangements progress with age in mdx. Furthermore, while the murine mdx 
model of Duchenne muscular dystrophy has been extensively described at the NMJ 
level, that for other mammalian models has not been. To fill this void, I analyzed 
morphological aspects of canine GRMD NMJs to discover if NMJ remodeling is a 
characteristic of all mammalian dystrophic synapses. 
                                               
1 The research presented below is adapted from Haddix SG, Lee Yi, Kornegay JN, 
Thompson WJ (2018) Cycles of myofiber degeneration and regeneration lead to 
remodeling of the neuromuscular junction in two mammalian models of Duchenne 
muscular dystrophy. PLoS ONE 13(10): e0205926  
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2.2. Materials and methods 
 
2.2.1. Mouse strains 
C57BL/10ScSn-Dmdmdx/J mice (mdx, RRID:IMSR_JAX:001801) were purchased from 
Jackson Laboratory and mated with transgenic mice expressing both a green fluorescent 
reporter expressed in Schwann cells, (B6:D2-Tg(s00B-EGFP)1Wjt/J, 
RRID:IMSR_JAX:005621) and a cyan fluorescent reporter expressed in motor axons 
(B6.Cg-Tg(Thy1-CFP)23Jrs/J, RRID:IMSR_JAX:003710). Use of these mice has been 
previously reported and all mice are available from Jackson Laboratories. Mdx mice 
were crossed into fluorescent mice, and progeny back crossed into mdx for 8 generations 
to ensure a C57BL/10 congenic background in fluorescent mdx mice. A pool of 4 -7 
male mice per genotype and age were used for each experiment, for a total of 111 mice 
in Sections 2 and 3. Experimental procedures in the formation and maintenance of 
neuromuscular synapses (2016-0158 or 2019-0179) protocol were approved by Texas 
A&M University IACUC.  
 
2.2.2. Mouse muscle preparation 
Mice were killed via I.P. injection of 0.15 mL of Euthasol. The sternomastoid muscle 
(STM) was dissected, pinned at resting length to a sylgard dish and fixed using 4% 
phosphate buffered paraformaldehyde (PFA) for 20 minutes. After fixation the muscles 
were washed three times with phosphate buffered saline (PBS) and labeled with α-
bungarotoxin conjugated to Alexa FluorTM 647 (ThermoFisher Scientific, Cat# 35450) 
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for 5 minutes (BTX, diluted 2 µg/mL in PBS). In some cases Fasciculin II (FasII) 
conjugated to AlexaFluorTM 647 was applied to muscles for 2 hours to label AChE 
(diluted 0.5 µg/mL in standard blocking solution). DAPI (Thermo Fisher Scientific Cat# 
D3571, RRID:AB_2307445) was used to label nuclei (diluted 0.5 µg/mL in PBS). After 
three PBS washes, a longitudinal “filet” from across the surface of the muscle was 
dissected from distal tendon to proximal tendon and mounted on a microscope slide in 
anti-fade fluorescence mounting medium.  
 
2.2.3. Image acquisition, and NMJ characterization and analysis 
Confocal micrographs were collected on either a Leica TPS II SP5 or a Zeiss LSM 780 
microscope using a 40X Oil objective (NA 1.4). Step size was set between 300-500 nm. 
Laser lines 405 nm, 458 nm, 488 nm, 563 nm, and 633 nm were used as necessary. 
Images were analyzed in ImageJ (ImageJ, RRID:SCR_003070) by creating maximum 
intensity projection images from collected stacks. Junctional area was calculated by 
thresholding the BTX labeled channel using the Auto Threshold tool provided by 
ImageJ. A polygon shaped region of interest was then circumscribed around the 
thresholded signal and the region of interest’s area measured. Receptor area was 
measured as the thresholded area of the BTX label within the circumscribed region of 
the AChR. Dispersion Index was calculated as receptor area/junctional area. The number 
of AChR fragments (fragmentation) was measured using the objects counter in ImageJ 
by setting the minimum area for counts as 5 µm2. This measurement protocol does not 
consider fragments in separate z-planes, as they may be superimposed in our maximum 
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intensity projections. Thus, these measurements are a conservative estimate of 
fragmentation, in that the actual number of fragments for both WT and mdx is likely 
underestimated. TSC counts were made by counting only fluorescently labeled Schwann 
cells in proximity to the endplate having coincident nuclear label via DAPI. Axon 
branch points were measured by creating 3D rotations of the confocal images of 
fluorescently labeled motor neurons, and then counting the number of times the axon 
splits. Small varicosities of the motor terminal were not counted as branches.  
 
2.2.4. Canine use 
Dogs were used and cared for in accordance with the National Research Council’s Guide 
for the Care and Use of Laboratory Animals and housed at Texas A&M University. 
Procedures used were approved by university IACUC protocol, Standard Operating 
Procedures-Canine X-Linked Muscular Dystrophy (2012-052 or 2015-0110). Ages of 
dogs ranged from 1 to 6 years. Two male and one female wild-type (WT) controls, two 
females hemizygous for the GRMD mutation (carriers), seven male GRMD dogs, and 
one myostatin heterozygote/GRMD (MSTN/GRMD) female were used for a total of 13 
animals. The animals used in these studies were undergoing necropsy for other purposes 
and the tissues shared. These dogs were part of a colony owned and maintained by Texas 
A&M University for research purposes. 
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2.2.5. Canine muscle preparations 
Following euthanasia for non-related procedures via I.V. injection of Euthasol, the 
middle portion of cranial tibial muscles was dissected and placed in 4% PFA for 20 
minutes. After fixation, the muscles were washed three times with PBS. Muscle fiber 
fascicles were dissected from the section and labeled with BTX conjugated to Alexa 
FluorTM 555 overnight in PBS (BTX, diluted to 2 µg/mL). Labeled fascicles were 
washed in PBS three times and then examined under a fluorescence dissecting 
microscope to identify the endplate band. A small portion of the fascicle containing the 
endplate band was cut from the fascicle and embedded in a 3% agarose gel. 40 µm 
longitudinal sections (parallel to the long axis of muscle fibers) were prepared using a 
vibratome. These sections were blocked using standard blocking solution (0.2% bovine 
serum albumin, 0.3% Triton 100X, 0.1% sodium azide in PBS) and labeled via mouse 
monocolonal antibodies to neurofilament (SMI-31, Covance, RRID:AB_531793, diluted 
4 µg/mL in standard blocking solution), synaptic vesicles (DSHB Cat# SV2, 
RRID:AB_2315387, diluted 4 µg/mL in standard blocking solution) and rabbit 
polyclonal antibodies to Schwann cells (S100, Dako Cat# Ga504, diluted 4 µg/mL in 
standard blocking solution) in PBS overnight. After three PBS washes, goat anti-rabbit 
secondary antibodies conjugated to AlexaFluorTM 647 (Thermo Fisher Scientific Cat# A-
21245, RRID:AB_2535813), and goat anti-mouse secondary antibodies conjugated to 
AlexaFluorTM 488 (Thermo Fisher Scientific Cat# A-11001, RRID:AB_2534069) were 
applied for two hours in PBS (diluted 2.5 µg/mL in standard blocking solution), along 
with BTX conjugated to AlexaFluorTM 555 (diluted 2 µg/mL in standard blocking 
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solution) and in some cases FasII conjugated to AlexaFluorTM 647 to label AChE 
(diluted 0.5 µg/mL in standard blocking solution). DAPI was used to label nuclei 
(diluted 0.5 µg/mL in standard blocking solution). Following three additional PBS 
washes, the sections were mounted on microscope slides using an anti-fade mounting 
medium.  
 
2.2.6. Statistics 
Mice: For analysis of mouse confocal images, STMs from 3-5 individuals of each group 
were used. Animals were grouped by approximate age and genotype (P38 WT, P38 mdx, 
etc). Five - 20 NMJs were imaged per muscle. NMJs were pooled for statistical analysis 
of confocal measurements. P38 animals were 38 ±	3 days old, P66 animals were 66 ±	3 
days old, and P450 animals over 450 days old at the time of death. Measurements were 
averaged and a Student’s t-test preformed to assess for significant differences between 
genotypes. Within genotypes but among ages, 2-Way ANOVA with Bonferroni post-hoc 
tests were used. The degrees of freedom (df) for each measurement is reported in text as 
t(df) = t-value, P-value. For t-tests performed on these measurements, the sample size n 
(number of pooled individual NMJs) was calculated as df + 2.  
 Canine: For measurements of dog confocal images, muscle preparations from 
two male and one female WT controls, two female carriers, seven male GRMD dogs, 
and one GRMD/MSTN female were used for a total of 13 animals. Twenty-50 NMJs 
were imaged per individual and measurements were made as described above in “Image 
acquisition and analysis”. These measurements were pooled by genotype. A 1-Way 
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ANOVA with a post-hoc Tukey’s test was performed between genotypes on averages of 
each measurement. The degrees of freedom for each measurement is reported in text as 
q(df) = q-value, p-value. Statistical analyses were performed using Prism GraphPad 5 
software, and statistical significance was set at P < 0.05. In figures and text, results are 
presented as means with SEM, unless otherwise noted.  
 
2.3. Results 
 
2.3.1. Mdx mice undergo progressive fragmentation of their AChR rich endplate 
Using fluorescence confocal microscopy, I found changes to NMJ morphology in 
mdx mice similar to those reported previously (Lyons and Slater, 1991; Minatel 
et al., 2003; Pratt et al., 2015a). I imaged mdx muscles near the onset of necrosis 
(P38) and onward. These changes were present in the youngest animals 
examined. Morphological differences were seen in older adult versus younger 
mdx animals, matching disease progression. When labeled with fluorescently 
tagged BTX, a highly specific ligand for the AChRs, the receptors at most 
individual mdx NMJs were fragmented into discontinuous aggregates. This 
differs from the pretzel-like receptor aggregates of WT animals, which are 
arranged into continuous branches (Figure 2.1A). Junctions with this abnormal 
clustering of AChRs have been classified as fragmented. Instead of continuous 
tracks of receptor accumulation, AChRs cluster into discrete islands (Lyons and 
Slater, 1991; Kong and Anderson, 1999; Pratt et al., 2015a). Maximum intensity 
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projections of confocal stacks were evaluated for the number of AChR fragments 
they contained. Mdx NMJs had more fragments than WT at all ages (Figure 
2.1B. Fragmentation: 336% increase at P38 t(32) = 7.974, P < 0.001, 77% 
increase at P66 t(75) = 4.756, P < 0.001, and 445% increase at P450, t(19) = 
7.186, P < 0.001, t-tests). Notably, at P38 in mdx, there was a population of both 
fragmented (56.7%) and continuous junctions. I think it is likely, as others have 
postulated (Minatel et al., 2003), that dystrophic junctions remodel from 
continuous to fragmented as the animals age, that this remodeling is stochastic in 
its occurrence, and that this process is irreversible. The irreversibility is 
suggested by two observations. First, the proportion of junctions that are 
fragmented increases as mdx mice age and does not fall. At early time points 
(P14), WT and mdx animals have roughly the same proportion of adult-like, 
continuous junctions (Minatel et al., 2003), but from P66 on nearly all the AChR 
aggregates at mdx NMJs are fragmented in appearance. Additionally, the degree 
of fragmentation becomes more severe as dystrophic animals age, with the 
number of fragments increasing from 7.3 in P38 mdx animals to 13.0 in P450 
mdx animals (Fig 2.1B. t(90) = 5.460, P < 0.001, 2-Way ANOVA, Bonferroni 
post-hoc test). In WT animals, no such increase from P38 to P450 was evident, 
and the average number of fragments at all ages was less than five. 
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Figure 2.1. WT and mdx NMJs. 
(A) Maximum intensity projection confocal images of P66 WT, P66 mdx and P450 mdx NMJs. Images from left to right: AChR, 
motor axon terminal arbor, tSCs, and composite images. In the composite image, AChRs are pseudocolored red, motor axons cyan, 
and tSCs green. Scale bar = 20 µm. “#” indicates examples of AChR fragments; arrowheads, examples of axon terminal branch 
points; asterisks cell bodies of tSCs. In P450 mdx, cells that cannot be positively identified as Schwann cells are evident. These cells 
are not labeled as tSCs in the panels nor included in measurements, and may be macrophages that express S100 and are plentiful in 
mdx tissue. (B) Junctional measurements in WT and mdx NMJs from P38 to P450 as described in “Image acquisition and analysis”. 
Asterisks above solid bars denote significance between genotypes (t-test, * P < 0.05, ** P < 0.01, *** P < 0.001). 15 to 90 NMJs 
were compared for each measurement. Dashed lines denote significance between ages (2-Way ANOVA, Bonferroni post-hoc test, P 
< 0.05).  
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2.3.2. Mdx mice undergo progressive NMJ expansion and a dispersion of AChRs 
within the synaptic area 
Fragmentation is one of the most striking postsynaptic changes in mdx NMJs, but 
other measurable differences were also evident. To approximate the size of the 
entire synaptic structure (i.e. the AChR aggregate, the motor axon terminal, and 
the tSCs), a polygon was drawn around the labeled receptor aggregate and its 
area was measured. This polygon included the totality of the receptors, but also 
included areas between the receptor aggregates that were not labeled with BTX. 
Thus, the polygon included areas containing tSC somata and processes, and the 
motor axon terminals ramifying above and between the synaptic contacts, even if 
these entities were not fluorescently labeled or imaged. I designate this 
measurement the junctional area. At all ages, the junctional area was larger in 
mdx than in WT (Figure 2.1B. P38 t(36) = 6.581, P < 0.001, P66 t(84) = 2.319, P 
= 0.0228, P450 t(19) = 2.537 P = 0.0201, t-tests). WT junctional area ranged 
from ~35% to ~80% of the mdx Junctional Area.  
There was also an increase in junctional area in mdx from P38 to P450 
(Figure 2.1B, t(90) = 5.089, P < 0.001, 2-Way ANOVA, Bonferroni post-hoc 
test), and P66 to P450 (Figure 2.1B, t(90) = 5.380, P < 0.001, 2-Way ANOVA, 
Bonferroni post-hoc test) that was not noted in WT animals. P450 mdx junctional 
area was about 2.5x that of P38 mdx.  
An effort was made to measure just the area that AChRs occupied on the 
sarcolemma, not including the motor axon and tSCs. The receptor area was 
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defined as the area within the junctional area that fluoresced intensely when 
labeled with BTX conjugated to an AlexaFluorTM marker. Mdx NMJs displayed 
increased receptor area from WT only at P38 and P450 (Figure 2.1B. P38, t(41) = 
3.284, P = 0.0021 and P450, t(24) = 2.195 P = 0.0381, t-tests). At P38, mdx 
receptor area was 1.3x as large as P38 WT, while at P450, mdx receptor area was 
1.5x as large as P450 WT. In WT endplates, there were no significant changes in 
receptor area throughout life. The receptor area in mdx increased from ages P38 
to P450 (Figure 2.1B. t(90) = 4.277, P < 0.001, 2-way ANOVA, Bonferroni post-
hoc test). There was no increase in receptor area from P38 to P66 in NMJs of 
mdx mice. It should be noted that receptor area is not a receptor density 
measurement. While the space that these receptors occupy on the myofiber 
increases, the density may or may not change at the same time. I chose not to rely 
on fluorescence intensity measurements to estimate receptor density, as this 
measurement varies with junctional position in the muscle preparation thickness.  
I also investigated the spread of receptors within the synaptic area. To 
quantify this spread, the receptor area was divided by the junctional area and 
termed the dispersion index (DI), a measure previously used by Pratt and 
colleagues (Pratt et al., 2015a). The lower this ratio the more spread there is of 
the receptor clusters within the junction. Junctions in the mdx animals were 
consistently more disperse, i.e. had a lower DI than age matched WT (Figure 
2.1B. P38 t(34) = 5.926 P < 0.001, P66 t(88) = 3.117, P = 0.0025, P450 t(38) = 
5.034, P < 0.001, t-tests). The DIs of mdx animals were ~70% - 90% of WT. The 
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spread of the receptors within the junction at P450 mdx is 1.2x that of P38 mdx 
animals (t(90) = 2.264, P < 0.05, 2-Way ANOVA, Bonferroni post-hoc test). As 
with fragmentation, this suggests that as mdx animals age, an increasing number 
of NMJs remodel from the healthy continuous state to the large, fragmented 
dystrophic state. These results also suggest that individual, dystrophic NMJs can 
become increasingly remodeled with time, a change not seen in older WT mice. 
By P66 nearly all the mdx NMJs are remodeled, but significant differences from 
P66 to P450 can be seen in all the postsynaptic characteristics measured in mdx. 
It is likely that ongoing degeneration and regeneration of the STM myofibers, not 
present in WT muscle, is driving these progressive alterations. 
 
2.3.3. Mdx NMJs undergo a remodeling of the presynaptic apparatus 
It has been established that mdx mice undergo bouts of myofiber necrosis and 
regeneration due to their high susceptibility to myofiber damage. This process along 
with concomitant motor terminal axon activity contributes to NMJ remodeling as noted 
in exogenous muscle damage (Li and Thompson, 2011). If the motor axon terminal is 
remodeled in a similar way in mdx to that of damage paradigms, it is possible that the 
same processes that remodel junctions following myofiber damage are the same that 
remodel in mdx and dystrophy. To investigate this possibility, measurements on the 
presynaptic apparatus of NMJs, namely the tSCs and motor axon terminal, were 
performed. Mdx animals were crossed to transgenic mice that express eGFP driven by 
the S100 promoter in Schwann cells (Zuo et al., 2004), and CFP in motor axons driven 
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by the Thy1 promoter (Feng et al., 2000). The number of motor axon branch points in 
proximity to the endplate was considered a measure of motor neuron terminal 
rearrangement. Branching pattern differences between mdx and WT animals were not 
significant except at P450 (Figure 2.1B. Branch Points, t(21) = 4.816 P < 0.001, t-test). It 
was noted, however, that the gross morphology of dystrophic terminal arbors was 
visually distinct from WT. As the motor neuron contacted the muscle fiber at the 
endplate of healthy WT animals, branches of the terminal tended to run smoothly along 
the tracks formed by the AChR gutters. Mdx axonal arbors were seen to have small, 
bulbous varicosities that made connections to the fragmented islands of AChRs (Figure 
2.1A). These varicosities were not counted as branches because they were very short. 
The number of axonal branches did increase from 7.5 to 11.1 (Figure 2.1B. t(52) = 
4.010, P < 0.001, 2-way ANOVA, Bonferroni post-hoc test) in mdx mice from P38 to 
P450. This trend was not apparent in WT mice, consistent with previous reports that 
normal junctions could grow and shrink without changing their branching pattern 
(Balice-Gordon and Lichtman, 1990), although slight changes in postsynaptic structure 
from P38 to P450 were noted in WT animals. 
The number of tSCs was counted for both mdx and WT junctions based 
on GFP expressed in these cells and coincident nuclear DAPI label (Figure 2.2).  
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Figure 2.2. Terminal Schwann cell identification. 
TSCs are identified by coincident DAPI and transgenic Schwann cells labelling. 
Arrowheads denote terminal Schwann cell somata identified in this manner. Scale bar = 
20 µm. 
 
 
Dystrophic endplates consistently had more tSCs than age matched WT 
endplates (Figure 2.1A, B. Terminal Schwann Cells, P38, t(8) = 2.880 P = 
0.0205, P66 t(33) = 3.655, P = 0.009, P450 t(21) = 6.711,  P < 0.001, t-tests). In 
mdx the number of tSCs increased with age, from P38 to P450 (Figure 2.1B. 
t(45) = 3.441, P < 0.01, 2-Way ANOVA, Bonferroni post-hoc test). The 
phenomenon was not apparent in WT mice. On average WT P38 animals had 2.8 
tSCs per NMJ, while P450 had 3.1. In contrast, at the same ages, mdx NMJs had 
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on average 5.0 tSCs at P38 and 7.9 at P450. These findings fit well with 
observations that tSCs are added to the NMJ during the process of junction 
growth during development (Love and Thompson, 1998). During periods of little 
to no growth in healthy adult mice, no tSCs are added. However, during the 
expansion of the endplate from P38 to P450 in mdx mice, as suggested by 
increased junctional area, there is also an expected addition of tSCs. 
  
2.3.4. GRMD dogs display similar changes in NMJ morphology to those in mdx 
mice 
Mdx mice have a mild phenotype and near-normal lifespan compared to humans 
afflicted with DMD. Therapies that are effective in treating dystrophic mice have 
not translated well to humans in clinical settings (Gussoni et al., 1999; Fletcher et 
al., 2007). We, therefore, sought to determine whether the morphological 
changes seen in mdx mice also occur in GRMD, a canine model more clinically 
relevant to DMD (Kornegay et al., 2012). I harvested the midsection of cranial 
tibial muscles in the hind limb of adult GRMD, WT, and carrier dogs at necropsy 
performed for other non-related experiments. Carriers were not used as controls 
as they are female dogs, hemizygous for the GRMD mutation, and there are 
reports of carriers manifesting certain aspects of the disease state (Emery, 1965; 
Bostick et al., 2008; Soltanzadeh et al., 2010). A single example of a myostatin 
heterozygote, dystrophin null (MSTN/GRMD) animal was also included. These 
animals have a mixed pattern of muscle atrophy and hypertrophy (Kornegay et 
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al., 2016). Acetylcholine receptors, Schwann cells, and motor neurons were 
labeled via immunofluorescence and BTX labeling. When imaged using confocal 
microscopy, changes to the NMJ like those in mdx mice were found. The 
postsynaptic AChR aggregate was clearly abnormal (Fig 2.3A). The same NMJ 
measurements made on murine synapses were also made for canine preparations. 
The NMJs of GRMD dogs were 1.8x as large as their WT counterparts (Figure 
2.4. Junctional Area, q(484) = 9.723, P < 0.001, 1-Way ANOVA, Tukey’s post-
hoc test). The spread of receptors in GRMD NMJs was 1.6x that of WT (Figure 
2.4. Dispersion Index, q(484) = 19.84, P < 0.001, , 1-Way ANOVA, Tukey’s 
post-hoc test). Finally, the number of fragments of AChRs was higher in 
dystrophic dogs than in WT (Figure 2.4. Fragmentation, q(484) = 15.09, P < 
0.001, 1-Way ANOVA, Tukey’s post-hoc test). WT animals had an average of 
1.6 fragments per NMJ, and GRMD 5.8. Generally, no difference in the 
postsynaptic morphology was noted between WT and carrier groups, or GRMD 
and MSTN/GRMD groups (Figure 2.3). Trends that held for WT vs GRMD also 
held for WT vs MSTN/GRMD, Carrier vs GRMD, and Carrier vs 
MSTN/GRMD. For example, MSTN/GRMD junctional area was increased from 
WT and Carrier NMJs, and GRMD junctional area was also increased from WT 
and carrier. For full assessment see Figure 2.4. A significant increase in receptor 
area was only recorded between carrier and GRMD animals (Figure 2.4. 
Receptor Area, q(484) = 5.030, P < 0.001, 1-Way ANOVA, Tukey’s post-hoc 
test), but receptor area for carriers was generally lower than all other groups. The 
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fact that differences between carriers and other groups were found at all, gives 
credence to the claims that carriers may have unrealized or mild phenotypes due 
to abnormal level of functional dystrophin (Soltanzadeh et al., 2010). While the 
distribution of dystrophin is uniform in carrier animals in adult hood, a mosaic 
pattern in the muscle fibers is observed earlier in life (Cooper et al., 1990). It is 
possible that the NMJ restructuring process in the carriers occurs when portions 
of the myofiber are more susceptible to damage due to lack of dystrophin 
expression. If this is the case it is unlikely that the morphology would revert back 
to that of a WT junction, as it is suggested that once an NMJ remodels it remains 
in its new morphology (see below).There was no statistically significant 
difference between WT and carrier, nor GRMD and GRMD/MSTN in any of the 
postsynaptic measurements.  
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Figure 2.3. Canine NMJ morphology. 
Confocal maximum intensity projection of adult WT, Carrier, GRMD, and 
MSTN/GRMD NMJs harvested from the cranial tibial muscle. Axon image from 
MSTN/GRMD missing due to lack of staining. Composite images pseudocolored red-
AChR, cyan-motor axon, green-tSC. Scale bar = 20 µm. Note the difference in 
magnification between top two and bottom two rows.  
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Figure 2.4. Canine NMJ measurements. 
Junctional measurements in WT and GRMD NMJs as described in “Image acquisition 
and analysis”. Solid lines between groups denotes no significant differences (ns). Dashed 
lines between groups denote significant differences. For example, there is no significant 
difference in Junctional Area between WT and Carrier, or GRMD and MSTN/GRMD. 
There is a significant difference between WT or Carrier and GRMD or MSTN/GRMD. 
Asterisks denote significant differences (** P < 0.01, *** P < 0.001). 1-Way ANOVA 
Tukey’s post-hoc test. 
 
 
When the presynaptic apparatus of the NMJ was investigated, no 
differences in the number of motor axon branches were noted between WT and 
GRMD (Figure 2.4. 1-Way ANOVA, Tukey’s post-hoc test), similar to the case 
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of younger mdx reported above. However, the number of branch points in 
carriers was significantly lower than WT (Figure 2.4. q(256) = 5.711, P < 0.001, 
1-Way ANOVA, Tukey’s post-hoc test) and GRMD (Figure 2.4. q(256) = 5.831, 
P < 0.001). In some preparations, it was evident that GRMD axon terminals also 
synapsed on the myofiber in varicosities (Figure 2.5) similar to that of mdx. 
However, this was not apparent in all images, and is likely due to incomplete 
labeling using the antibodies to synaptic vesicles and neurofilament.  
 
 
 
Figure 2.5. Motor axon varicosities in GRMD. 
Maximum projection confocal images of a GRMD NMJ from the cranial tibial muscle. 
Arrows indicate bulbous varicosities in the nerve terminal. Not all varicosities are noted 
in the image. In composite image AChR are pseudocolored red and motor axons cyan. 
Scale bar = 20 µm. 
 
 
Consistently weaker labeling was observed in the canine preparations 
than those obtained in mice. It is possible that older GRMD dogs would show 
increased changes like those in the P450 mdx mice, but this was not investigated. 
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Finally, there was no difference in the number of tSCs between GRMD and WT 
dogs, but again immunofluorescent labeling was the method used in dog 
preparations.  In mouse investigations, the use of transgenic fluorescent proteins 
in the Schwann cells and the motor neurons allowed for more faithful labeling. 
Carriers, however, had less tSCs than GRMD (Figure 2.4. q(142) = 6.174, P < 
0.001, 1-Way ANOVA, Tukey’s post-hoc test) and GRMD/MSTN (Figure 2.4. 
q(142) = 5.111, P < 0.01, 1-Way ANOVA, Tukey’s post-hoc test). Again, this 
indicates a potential subclinical phenotype in non-manifesting carriers of DMD. 
Alternatively, as all carriers are by necessity female, as GRMD is an X-linked 
genetic disease, there may be sex differences in the NMJ morphology. I 
attempted to control for this by including both male and female dogs in the WT 
group. Regardless, the similarities between mdx and GRMD NMJs suggest that 
remodeling occurs in all mammals that lack dystrophin. This includes boys with 
DMD. What exactly is causing these changes has not been satisfactorily 
investigated, however. In Section 3, I was able to investigate if myofiber 
degeneration and regeneration were indeed causative in remodeling in dystrophy. 
 
2.3.5. Ghost junction observations 
AChE is an enzyme tethered to the basal lamina within the synaptic cleft, and is critical 
to the function of the synapse. Because it is attached to the dense collagen matrix of the 
basal lamina, and not part of the muscle, nerve, or tSCs, following the removal of any of 
these cellular components of the NMJ, AChE will remain. Labeling with FasII, a toxin 
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like BTX that binds the AChE, allows researchers to identify areas on the muscle fiber 
that were previously NMJs even in the absence of other markers, like AChR. “Ghost” 
junctions, NMJs that retain AChE but have no indication of AChR, have been used to 
mark areas of myofiber degeneration at the endplate area. In both mdx and GRMD 
muscles, ghost junctions were found (Figure 2.6). In many cases, these had an abnormal 
appearance. The innervating axon remained and had bulbous varicosities presumably 
sitting on the myofiber where receptor had been previously. This observation 
substantiates the hypothesis that myofiber degeneration and regeneration does occur at 
the synaptic area and may somehow be linked to NMJ remodeling in muscular 
dystrophy. 
 
 
 
Figure 2.6. Canine ghost junction. 
Maximum projection confocal micrographs of GRMD NMJ labeled with BTX, FasII. 
SMI-31 and SV2, for AChR, AChE, neurofilament, and synaptic vesicles respectively. 
Arrowheads denote ghost junctions. Right most panel is a composite image with AChR 
pseudocolored red, AChE green, and motor axon cyan. Yellow shows colocalization of 
AChR and AChE. Scale bar = 20 µm.  
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2.4. Discussion 
The morphological abnormalities that are evident in mouse mdx NMJs also occur 
in the more clinically relevant canine GRMD model and the same processes that 
instruct remodeling mice likely also occur in GRMD. This suggests that NMJ 
remodeling is a common consequence of muscular dystrophy in all animals, 
including human DMD patients. It has been suggested that DMD NMJs are also 
fragmented, but this was assessed in cross sectional slices of myofibers, which 
does not give a fully realized assessment of the NMJ morphology (Theroux et al., 
2008). Non-diseased human NMJs, however, display increased levels of 
fragmentation from WT mice (Jones et al., 2017), and the morphology does not 
change drastically throughout human life span, unlike mice. I provide evidence 
that the remodeling of mdx NMJs progresses with age, likely as a result of 
ongoing degenerative and regenerative events that occur in STM of mdx mice.  
Muscle fiber damage has been shown to rearrange the NMJ. Based on 
observations in vivo of deliberate muscle fiber damage, this is thought to occur 
through the motor axon terminal, which is normally directly opposed to the 
receptor islands that appear after regeneration of each damaged fiber. The motor 
terminal was found to extend processes along the regenerating muscle fiber and it 
was proposed that the motor neuron directs the insertion of AChRs into new 
contact sites in the sarcolemma, resulting in a larger and fragmented endplate 
with a more complex motor axon terminal arbor (Li and Thompson, 2011). It is 
probable this phenomenon is occurring in dystrophic mice as well. 
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 The tSCs of the dystrophic NMJ may also be contributing to the changes 
in morphology. When the activity of these glial cells is modified, NMJs are 
observed to be more fragmented in appearance without any indication of muscle 
fiber damage (il Lee et al., 2016). In dystrophic animals others and I noted 
changes to the tSCs, including increased number and the appearance of cellular 
processes (Personius and Sawyer, 2005). Sprouting of tSCs and axonal processes 
to nearby NMJs, however was not noted. When tSC number was plotted against 
fragmentation no significant correlation was noted, and thus not presented. I 
suggest that the main cause of NMJ remodeling is myofiber injury, but cannot 
totally discount that tSC activity also plays a role.  
 Fragmentation of the AChR aggregate is perhaps the most profound and 
progressive change seen in the mdx endplates. The vast increase in the number of 
fragments from the earlier time points (P38 and P66) to P450 is quite evident 
even without the use of descriptive statistics. An increase and then decrease in 
the number of fragments was noted in WT animals during the time course 
studies. However, this likely does not indicate the same remodeling process seen 
in mdx animals. While the maximum number of fragments in WT animals was 
recorded as 10 at P66, the maximum number of fragments in mdx was over 15 at 
all ages and in some cases reached over 20. The average number of fragments for 
WT animals was always under 5 for each age, which in some reports is used as 
the distinction between a non-fragmented and fragmented endplate (Valdez et al., 
2010). Again, the change in the mdx animal seems to be permanent. 
  
58 
 
Observationally, past the P38 time point in STM no pretzel like endplates were 
seen. If fragmented junctions could return to a normal appearance, at least a 
small proportion of endplates would be pretzel-like. While some mdx are indeed 
more continuous in nature, they still look abnormal and resemble fragmented 
junctions whose receptor islands have collapsed into each other, not the normal 
AChR ribbons seen in WT. 
I do not think that many of the changes seen in dystrophy, such as 
increase in junctional area, are due to increases in muscle fiber diameter. As 
muscle fibers grow, the receptor aggregate upon them also increases in size. One 
could postulate that the increase in junctional area of mdx junctions is a function 
of increased dystrophic muscle fiber size, possibly due to hypertrophy. This 
hypothesis does not hold under scrutiny for one decisive reason. While variation 
in muscle fiber cross sectional area is higher in mdx, the average myofiber cross 
sectional area is no different between WT and mdx animals (Coulton et al., 
1988a; Briguet et al., 2004). This shows that the size of a dystrophic junction 
grows at a rate that is not mimicked by the myofiber cross sectional area. 
Observationally, much of the increase in dystrophic NMJ size occur along the 
length of the myofiber, though a direct measurement of the axis of growth was 
not made. An effort was made to sample a repertoire of NMJs in different lateral 
sections of the muscle filet to not skew our results towards a certain NMJ 
morphology. However, only superficial myofibers were assessed. If these 
myofibers on the outside of muscle are morphologically dissimilar to inner 
  
59 
 
fibers, our conclusions may be biased towards the larger fragmented NMJs of 
mdx animals. The same prep was used on WT muscles. 
 While many have postulated that the NMJ changes in mdx animals are due to 
myofiber damage, there has been little direct investigation of the link between these 
phenomena. Other investigators have correlated central chains of nuclei within a 
myofiber to fragmented junctions (Lyons and Slater, 1991), but it is unclear if central 
nuclei are a marker for recent myofiber regeneration. Historically, myofibers with nuclei 
in the center of the cytoplasm instead of the periphery have been used to identify 
regenerated muscles (Benoit and Belt, 1970). Unfortunately, this method of investigating 
regeneration has its drawbacks. For one, the time course over which myonuclei move 
from the center to the periphery of the fiber may be very long and not indicate truly 
recent regeneration (Wada et al., 2008). The incidence of encountering ghost junctions in 
dystrophic tissue, however, gave a further indication that myofiber degeneration was 
occurring at synaptic sites. This is worth noting as a homolog of dystrophin, utrophin is 
concentrated at the NMJ, and could have been providing a protective role against 
contraction induced damage. Upregulation of utrophin has in fact been shown to 
decrease the incidence of damage in mdx mice (Tinsley et al., 1998; Gilbert et al., 1999). 
The endplate area of the muscle, however, does not appear to be spared from 
degenerative and regenerative events. Ghost junctions, while not arranged in the 
classical fragmented appearance of dystrophic postsynaptic apparatus, did display 
changes to the presynaptic apparatus. Ghost junctions may indicate a step in the 
remodeling pathway, that occurs following myofiber degeneration. The nerve terminal 
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may then rearrange, and upon regeneration of the myofiber the AChR aggregate could 
also remodel as suggested by myofiber injury experiments (Li et al., 2011; Li and 
Thompson, 2011). In subsequent sections, I use a technique to identify recently 
regenerated myofibers at the synaptic site, and correlate this to the process of NMJ 
remodeling. 
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3. CAUSES OF NMJ REMODELING IN MDX2 
 
3.1. Research impetus 
Finding that two models of muscular dystrophy share a similar NMJ phenotype 
(Section 2), there was justification for investigating what causes these changes in 
mdx mice, as it is probably conserved in all mammals that lack the dystrophin 
protein. It has long been hypothesized that muscle degeneration and regeneration 
is the initial insult that results in NMJ remodeling. This is supported by 
experimentation showing fragmentation of the receptor endplate in deliberately 
damaged muscle fibers of healthy mice. It is well established that lack of 
dystrophin leaves muscle fibers more susceptible to contraction-induced damage 
(Moens et al., 1993). So, the linkage of two phenomena is well founded. Further 
indirect evidence that muscle fiber damage causes NMJ remodeling can be found 
when AChE is used as an indicator of muscle degeneration. AChE remains 
tethered to the basal lamina even after muscle fiber degradation; however, AChR 
is destroyed along with the muscle fiber membrane. NMJs with strong AChE 
label following damage, and weak or absent AChR, have been termed ghost 
                                               
2 The research presented below is adapted from Haddix SG, Lee Yi, Kornegay JN, 
Thompson WJ (2018) Cycles of myofiber degeneration and regeneration lead to 
remodeling of the neuromuscular junction in two mammalian models of Duchenne 
muscular dystrophy. PLoS ONE 13(10): e0205926  
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junctions. Ghost junction labeling has allowed researchers to determine the 
location of previous endplate areas, even in the absence of AChR labeling. 
Frequently, small puncta of AChR are detected directly under the strong AChE 
label, indicating receptor tethering to the basal lamina as well. In dystrophic 
muscle preparations, an increased incidence of ghost junctions suggests 
significant muscle fiber degeneration at the endplates of dystrophic muscles.  
Neither a causal relationship, nor a direct correlation, between muscle 
fiber damage caused by dystrophy and NMJ remodeling have been adequately 
investigated. Using a methodology that detects changes in AChR loss and 
replacement from the sarcolemma over time, I have investigated whether NMJ 
remodeling is correlated with muscle fiber degeneration and regeneration in 
dystrophic mice. This method only allows us to make these correlations, but also 
examine whether myofiber degeneration and regeneration are ongoing 
phenomena in mdx mice. As mentioned before, the loss of dystrophin in mice is 
associated with early myofiber damage that stabilizes after about 12 weeks.  
The research outlined here in Section 3 indicates that receptor 
replacement, due to muscle cell degeneration and regeneration, in mdx is 
associated with NMJ remodeling, and that in the STM myofiber injury is 
occurring at a constantly higher rate. Elevated myofiber degeneration is not 
confined to a crisis period in mdx STM. In muscle fiber injury paradigms, the 
motor axon terminal has a dominant role in remodeling (Li and Thompson, 
2011), and the same is true in dystrophy as reported below. Myofiber 
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degeneration and regeneration triggers both presynaptic and postsynaptic 
apparatus rearrangement. While it has been suggested that a similar phenomenon 
takes place in mdx muscle fibers (Marques et al., 2007), this link needed further 
investigation. Here, I demonstrate that remodeling of the NMJ in mdx is initiated 
by myofiber injury, but that  the motor axon terminal must be present for 
remodeling to occur.  
 
3.2. Materials and methods 
 
3.2.1. Mouse strains 
Mice were generated as in Section 2.2.1. Three to seven male mice per genotype and age 
were used for each experiment, for a total of 111 mice in Sections 2, 3. Experimental 
procedures in the formation and maintenance of neuromuscular synapses (2016-0158 
and 2019-0179) protocol were approved by Texas A&M University IACUC.  
 
3.2.2. In vivo two-color α-bungarotoxin 
Mice were anesthetized via isoflurane inhalation and placed in a supine position. 
To investigate the STM, neck hair was removed using a depilatory and the 
surgical site sterilized with povidone-iodine. An incision was made from chin to 
sternum and the skin retracted. The salivary glands were moved to the side to 
expose the STM. Surrounding connective tissue was gently removed and a non-
saturating concentration (diluted 2 µg/mL in sterile lactated Ringers) of α-
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bungarotoxin conjugated to Alexa FluorTM 555 (ThermoFisher Scientific, Cat# 
35451) applied to the surface of the muscles for 5 minutes (BTX-1). The neck 
cavity was then washed copiously with lactated Ringer’s ten times. For muscle 
injury experiments, superficial muscle fibers at areas close to the site of entry of 
the accessory nerve into the muscle were cut with a sterile #15 surgical scalpel. 
The contralateral muscle was also labeled with BTX-1, but not injured and used 
as an internal control (IC). For denervation experiments both STM muscles were 
labeled with BTX-1 and the accessory nerve of one STM was severed near its 
insertion site into the muscle. The other muscle was spared and used as an IC. 
The salivary glands were moved back into place following labeling, washing, and 
injury. The skin was sutured with 8-0 silk and treated with 2% lidocaine 
hydrochloride jelly. Animals were allowed to convalesce for ten days post-
surgery. Endpoints for the studies are labeled P38, P66, P160, and P450. P38 
animals were 38 ±	3 days old, P66 animals were 66 ±	3 days old, P160 animals 
were P160 ± 3 days old, and P450 animals over 450 days old at the time of 
death. A similar protocol was used to investigate receptor replacement in the 
tibialis anterior (TA) of WT and mdx mice. An incision was made near the tarsal 
joint of mice that reached to above the knee. The skin was separated and the 
connective tissue surrounding the TA was gently removed. A 1:500 dilution of 
BTX-1 in Ringer’s was continuously dripped onto the muscle for 5 minutes, and 
followed by a 5-minute Ringer’s drip. The wound was closed using an 8-0 silk 
suture and the animal allowed to convalesce for 10 days. In order to match 
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previous research describing the cellular pathology of the mdx TA end points of 
P31, P45, and P100+ were used. Mice were killed via I.P. injection of 0.15 mL of 
Euthasol. The STM or TA was dissected, pinned at resting length to a sylgard 
dish and fixed using 4% PFA for 20 minutes. After fixation, the muscles were 
washed three times with PBS and labeled with α-bungarotoxin conjugated to 
Alexa FluorTM 647 (ThermoFisher Scientific, Cat# 35450) for 5 minutes (BTX-2, 
diluted 2 µg/mL in PBS). DAPI (Thermo Fisher Scientific Cat# D3571, 
RRID:AB_2307445) was used to label nuclei (diluted 0.5 µg/mL in PBS). After 
three PBS washes, a longitudinal filet from across the surface of the muscle was 
dissected from distal to proximal tendon and mounted on a microscope slide in 
anti-fade fluorescence mounting medium.  
 
3.2.3. Image acquisition, and NMJ characterization and analysis 
Junctions were counted and categorized using a Leica DMRX epifluorescence 
microscope and a 40X Oil objective (NA 1.4). Junctions were considered fragmented if 
they had 5 or more non-connected clusters of AChRs in close proximity to each other on 
the same myofiber. Junctions were categorized based of the brightness of BTX-1 and 
BTX-2 labels, as well as if they were continuous (< 5 AChR clusters), or fragmented (> 
5 AChR clusters). They were classified as stable if BTX-1 and BTX-2 labels were both 
bright, or as dynamic if BTX-1 label was totally or mostly absent and BTX-2 label 
bright. In many cases dynamic junctions did not completely lose BTX-1, and small 
puncta of fluorescence was seen. It is likely that these puncta are BTX-1 labeled 
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receptors tethered to the basal lamina and demarcate the initial synaptic site before 
myofiber degeneration. If both the BTX-1 and BTX-2 labels were faint, junctions were 
classified as lost, but this was rarely observed. In order to verify that dynamic junctions 
indeed lose their BTX-1 label, a subset of STMs were removed immediately following 
the initial exposure, at Day 0 without any convalescence. After dissection, the Day 0 
muscles were labeled with BTX-2. In all junctions BTX-1 and BTX-2 labels were bright 
and junctions were all categorized as stable. Characterization and counts were performed 
by multiple researchers on the same muscle preparation, and similar results obtained. 
Fifty - 100 NMJs were characterized for each muscle preparation.  
Confocal micrographs were collected on either a Leica TPS II SP5 or a Zeiss 
LSM780 microscope using a 40X Oil objective (NA 1.4). Step size was set between 
300-500 nm. Laser lines 405 nm, 458 nm, 488 nm, 563 nm, and 633 nm were used as 
necessary. Images were analyzed in ImageJ (ImageJ, RRID:SCR_003070) by creating 
maximum intensity projection images from collected stacks. Junctional area was 
calculated by thresholding the BTX-2 labeled channel using the Auto Threshold tool 
provided by ImageJ. A polygon shaped region of interest was then circumscribed around 
the thresholded signal and the region of interest’s area measured. Receptor Area was 
measured as the thresholded area of the BTX label within the circumscribed region of 
the AChR. Dispersion Index (Pratt et al., 2015a) was calculated as receptor 
area/junctional area. The number of AChR fragments (fragmentation) was measured 
using the objects counter in ImageJ by setting the minimum area for counts as 5 µm2. 
This measurement does not consider fragments in separate z-planes, as they may be 
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superimposed in our maximum intensity projections, and it is a conservative estimate of 
fragmentation. The actual number of fragments for both WT and mdx is likely 
underestimated by this measurement. tSC counts were made by counting only 
fluorescently labeled Schwann cells in proximity to the endplate having coincident 
nuclear label via DAPI. Axon branch points were measured by creating 3D rotations of 
the confocal images of fluorescently labeled motor neurons, and then counting the 
number of times the axon splits. Small varicosities of the motor terminal were not 
counted as branches.  
 
3.2.4. Statistics 
For analyses of mouse confocal images, STMs from 3-5 individuals of each group were 
used. Animals were grouped by approximate age and genotype (P38 WT, P38 mdx, etc). 
5-20 NMJs were imaged per muscle. NMJs were pooled for statistical analysis of 
confocal measurements. P38 animals were 38 ±	3 days old, P66 animals were 66 ±	3 
days old, P160 animals were P160 ± 3 days old, and P450 animals over 450 days old at 
the time of death. P450+ mdx animals age average was 459.25 days, and WT 554.5 
days. Measurements were averaged and a Student’s t-test performed to assess for 
significant differences between genotypes. Within genotypes but among ages, 2-Way 
ANOVA with Bonferroni post-hoc tests were used. The degrees of freedom for each 
measurement is reported in text as t(df) = t-value, P-Value. For t-tests performed on 
these measurements the sample size n (number of pooled individual NMJs) can be 
calculated as df + 2.  
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For receptor replacement values and NMJ categorization (e.g. stable, continuous; 
dynamic, fragmented…), 4-7 animals per genotype and age were used. 50-100 junctions 
were categorized per muscle, based on the brightness of the BTX-1 label (e.g. stable, 
dynamic) and the morphology of the BTX-2 label (e.g. continuous, fragmented, or lost). 
Lost junctions are considered dynamic. Category counts were then transformed into 
percentages of total counted NMJs for each muscle prep. These percentages were 
averaged between groups (P38 WT, P66 mdx…). 2-Way ANOVA with Bonferroni post-
hoc analyses were performed to assess significant differences both between genotypes 
and within genotypes. The degrees of freedom for each measurement is stated in text as 
t(df) = t-value, P-value. For statistical tests performed on these measurements, the 
sample size n (the number of mice compared) can be calculated as df + 2. Statistical 
analysis was performed using Prism GraphPad 5 software (GraphPad Prism, 
RRID:SCR_002798). Statistical significance was set at P < 0.05. In figures and text, 
results are presented as means with SEM unless otherwise noted.  
 
3.3. Results 
 
3.3.1. AChR replacement is elevated in mdx mice throughout life 
I investigated whether the dynamics of the AChR expression and distribution 
could provide evidence of how the dystrophic NMJ becomes remodeled. The 
rationale behind the approach is that loss of receptors from the myofiber 
membrane, due to sarcolemma breakdown at the endplate area during necrosis, 
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should indicate recent degeneration of the myofiber (Li et al., 2011). Upon 
subsequent regeneration of the myofiber, new AChRs would be inserted into the 
membrane, allowing the resumption of neuromuscular transmission. A loss of 
receptors coincident with abnormal endplate morphology would suggest that 
necrosis and regeneration spurs morphological changes to the NMJ. Not only 
could the removal of receptors be correlated to changes in NMJ structure, this 
technique would allow us to determine if a crisis period of elevated myofiber 
degeneration is occurring in the labeled muscles, and if synaptic regions of the 
myofiber are spared from degenerative processes. If a crisis period is occurring, 
then receptor replacement in mdx muscles would initially be much elevated 
compared to WT, but then drop to lower levels. 
To investigate this possibility, the AChRs of STMs and TAs were labeled 
with a sub-saturating dose of fluorescently tagged BTX (BTX-1) in live mdx and 
WT mice (Figure 3.1). The concentration and exposure time have previously 
been shown to not affect neuromuscular transmission or NMJ morphology 
(Akaaboune et al., 1999). Following a 10-day recovery period (endpoints of P38, 
P66, P160, and P450+) that allows for the occurrence of any ongoing myofiber 
degeneration and regeneration, the labeled muscle was dissected from the animal 
and labeled with a second spectral variant of fluorescently tagged BTX (BTX-2). 
This method is termed the in vivo two-color BTX method (Figure 3.1).  
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Figure 3.1. Two-color BTX experimental design and outcomes. 
Two-color BTX experimental design. The STM or TA of mice was exposed and labeled 
with BTX-1 at Day 0 (BTX-1 column). The animal was allowed to recover from the 
surgery for 10 days (Recovery column) and then euthanized. The labeled muscle was 
dissected from the animal and labeled with BTX-2 (BTX-2 column). The lower portion 
illustrates four predicted outcomes of the experiment. In red is a possible morphology of 
BTX-1 labeled AChR aggregates at Day 0 of the experiment, in green BTX-2 label at 
Day 10. Colocalization of BTX-1 and BTX-2 is indicated with yellow. Intact myofibers 
are shown as pink tubes, and a degenerating myofiber is shown as a gray tube. Scenario 
1 shows a stable, continuous junction. 2 a dynamic, fragmented junction. 3 a stable, 
fragmented junction, and 4 another dynamic, fragmented junction. Please note that 
because I do not image the junctions at Day 0, both scenario 2 and scenario 4 would be 
recorded as the same type of NMJ, a dynamic, fragmented junction. 
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Using epifluorescence microscopy, STM junctions were categorized 
based on both their morphology (fragmented or continuous) and the presence of 
each of the two spectral labels. If BTX-1 was lost and BTX-2 was bright, 
junctions were categorized as dynamic. If the brightness of the BTX-1 label was 
similar to BTX-2, junctions were categorized as stable (Figure 3.1 and 3.2A). If 
both BTX-1 and BTX-2 were weak, the junction was categorized as lost. It has 
been noted that there is rarely a complete removal of the BTX-1 label even after 
a bout of myofiber degeneration that follows deliberate damage to fibers. This 
residual label appears punctate and probably marks the initial synaptic site 
where, as mentioned earlier, some receptors remain tethered to the basal lamina 
after myofiber degradation (Slater, 1990; Li and Thompson, 2011).  
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Figure 3.2. Two-color BTX results.  
(A) Maximum intensity projection images of STM whole mounts that have undergone 
the two-color BTX procedure. Examples are from P66 mice. BTX-1 is the first receptor 
label. BTX-2 is the second applied 10 days later. The WT NMJ is stable continuous, and 
the mdx NMJ dynamic fragmented. Imaging follows muscle dissection. In mdx there is a 
loss of BTX-1 and frequently the BTX-2 label shows fragmentation. Scale bar = 20 µm 
(B) and (C) Receptor replacement in WT and mdx. Dots indicate individual data points. 
Receptor replacement, calculated as percentage of dynamic junctions, in mdx mice is 
constantly elevated compared to WT. Asterisks denote significance (* P < 0.05, *** P < 
0.001, 2-Way ANOVA, Bonferroni post-hoc test). No effect of age was found on 
receptor replacement for either muscle, but there is a trend towards less replacement at 
P100+ in mdx TA. 
 
 
In WT mice, receptor replacement, measured as the frequency of dynamic 
junctions, in STM is consistently low from P38 (Figure 3.2B), indicating no 
dramatic loss of receptors over the 10-day interval. However, when mdx animals 
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were investigated at P38, the proportion of dynamic junctions in the STM was 
3.3x to 10x as large as WT controls (Figure 3.2B). Lost junctions were 
considered dynamic in these measurements, as they also indicate degeneration of 
the myofiber.  
Surprisingly, there was no significant effect of age on the frequency of 
dynamic junctions in mdx muscles, indicating that receptor replacement in the 
STM is not confined to an early period during the lifetime of mdx mice, but 
occurs constantly from P38 to P450 (Figures 3.2B; P38 t(9)= 6.468, P < 0.001, 
P66 t(6) = 5.433, P < 0.001, P160 t(6)= 5.712, P < 0.001, P450 (6) = 3.719, P < 
0.01, 2-Way ANOVA, Bonferroni post-hoc test). While dynamic junctions were 
used in this report to measure myofiber degeneration and regeneration, there was 
some evidence of central chains of nuclei directly under dynamic, fragmented 
junctions (A-1). It is possible that like the diaphragm of mdx mice, the STM does 
not undergo a crisis period and muscle fiber damage occurs constantly 
throughout the its life.  
The TA had elevated receptor replacement in mdx as compared to WT at 
only P45 (Figure 3.2C; P45 t(15) = 3.078, P < 0.05, 2-Way ANOVA, Bonferroni 
post-hoc-test). While frequency of dynamic junctions was not affected by age in 
genotype, there was a trend in mdx TA of decreased receptor replacement at 
P100+. This could indicate that the TA, a hind limb muscle, may indeed be 
undergoing a crisis period, as has been suggested by previous researchers 
(Dangain and Vrbova, 1984). 
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Figure 3.3. P38 mdx NMJ characterization and reproducibility (40X).  
Maximum intensity projection images of P38 mdx NMJs following in vivo two-color BTX method. In 
composite BTX-1 is pseudocolored red and BTX-2 green. Yellow indicates strong colocalization. Black 
arrows denote stable, continuous junctions. Black arrow heads denote stable, fragmented junctions. White 
arrow heads denote dynamic, fragmented junctions. Asterisks denote lost junctions. Please note the 
presence of both dynamic and stable junctions in proximity to each other. This shows that receptor 
replacement occurs at individual junctions independent of neighboring endplates. This suggest that the 
absence of dystrophin does not simply shorten AChR half-life and that catastrophic receptor loss and 
replacement are likely due to myofiber degeneration and regeneration. Scale bar = 20 µm.  
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Figure 3.4. P38 and P66 NMJ characterization and reproducibility (20X). 
Maximum intensity projection images of P38 and P66, mdx and WT NMJs following in 
vivo two-color BTX method. In composite BTX-1 is pseudocolored red and BTX-2  
(continued) 
green. White arrows show examples of dynamic, continuous junctions. White arrow 
heads denote dynamic, fragmented junctions. Scale bar = 50 µm. 
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When the morphology of junctions was assessed between mdx and WT 
animals, I noticed that the predicted decrease in the number of stable, continuous 
junctions in P38 mdx (Figures 3.3 and 3.5. t(9) = 12.10, P < 0.001, 2-Way 
ANOVA, Bonferroni post-hoc test) was accompanied by an increase in the 
number of dynamic, fragmented junctions (Figure 3.5. t(9) = 5.763, P < 0.001, 2-
Way ANOVA, Bonferroni post-hoc test). This suggested that junctions shift from 
continuous to fragmented during muscle regeneration. Fragmentation and 
remodeling of the NMJ is a response to muscle fiber regeneration, that follows 
the degeneration of muscle cells. It is not that P38 muscles were used in this 
investigation (Figures 3.3 and 3.4), as after this time point a great majority of 
mdx endplates are fragmented, and once fragmented NMJs were not shown to 
revert back to a continuous morphology (Figure 3.4). This was also demonstrated 
by the constant characterization profile seen from P66 to P450 in mdx mice 
(Figure 3.5). That is to say stable, fragmented junctions were consistently more 
frequent than stable continuous, as well as an increased frequency of dynamic 
fragmented more frequent than dynamic continuous. Once lost stable, continuous 
junction frequency did not increase. The proportion of stable, fragmented 
junctions in mdx mice remained at about 60%, and the proportion of dynamic, 
fragmented junctions remains at about 30% from P66 to P450+. Stable, 
fragmented junctions indicate NMJs that were remodeling prior to the two-color 
BTX experiment, and these synapses did not undergo a degenerative process 
during the 10-day recovery period. 
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There was a shift in the characterization profile from P160 to P450+ 
when WT animals are observed. A noticeable increase in the amount of stable 
fragmented junctions in these older WT animals was seen. This is likely due to 
an increased amount of myofiber damage, as indicated by the receptor 
replacement elevation in Figure 3.2, which is simply a consequence of aging 
(Figure 3.2B). As the myofibers accumulate damage, one would expect to see an 
increase in frequency of the fragmented (or remodeled) junctions.  
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Figure 3.5. Two-color BTX NMJ categorization. 
Categorization of WT and mdx junctions from P38 to P450+. Dots within the graph are 
individual data points. Dashed lines above graph denote significant differences between 
genotypes. Solid bars below graph indicate significant differences within genotypes (2-
way ANOVA, Bonferroni post-hoc test, P < 0.05) A full account of statistical 
significance, including differences within genotypes can be found in A-2. 
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 In P38 mdx animals, the two NMJ morphologies present allowed us to 
assess whether receptor replacement has any bearing on NMJ morphology. When 
the morphologies of dynamic junctions were compared within P38 mdx animals 
dynamic, fragmented junctions were seen at a higher frequency than dynamic, 
continuous (Figure 3.5. t(30) = 5.992, P < 0.001, 2-Way ANOVA, Bonferroni 
post-hoc test). Again, this suggests that in mdx animals, AChR replacement is 
associated with NMJ remodeling. This correlation was not apparent in P38 WT 
animals. In WT animals, I found a small fraction of dynamic junctions (both 
fragmented and continuous) with no significant difference between their 
morphologies (Figure 3.5). While I predicted that in both WT and mdx mice 
dynamic junctions would preferentially be fragmented, the WT observation that 
receptor replacement had no effect on junction morphology may be a result of the 
overall low levels of fiber damage even in normal muscles. Or alternatively, 
endplates may have to suffer from multiple bouts of injury in order to trigger the 
remodeling phenomenon. As such, any striking differences in the morphology of 
dynamic junctions might have been masked. While not indicated in Figure 3.5 
for sake of brevity, a full account of NMJ categorization differences within 
genotypes (i.e. dynamic fragmented vs stable fragmented) is presented in A-2.  
Overall, these results suggest that cycles of myofiber degeneration and 
regeneration lead to remodeling of their junctions in dystrophy. An alternative 
explanation is that more rapid receptor replacement is a characteristic of mdx 
junctions because dystrophin tethers receptors to the membrane, as suggested 
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from gamma counting of radio labeled AChRs in whole muscles (Xu and 
Salpeter, 1997). This is unlikely, however, given the presence of both dynamic 
and stable junctions in the same muscle (Figures 3.3 and 3.4). Elevated receptor 
replacement was encountered at only a subset of junctions. In fact, dynamic 
junctions were observed on fibers neighboring those with stable junctions. If 
dystrophin loss causes a decrease in AChR half-life as suggested in previous 
research (Xu and Salpeter, 1997)it would be expected that individual endplates 
would all lose similar amounts of receptors. Also, this rapid replacement is not a 
constant characteristic of all fragmented junctions. Many fragmented junctions 
still retain high levels of BTX-1 (i.e. were classified as stable), suggesting that 
they suffered damage before, rather than during, the 10-day experimental period. 
Thus, these experiments suggest that the increased receptor replacement is 
caused by myofiber necrosis resulting from mdx muscle’s increased 
susceptibility to damage. I suggest the receptor replacement is not a primary 
effect of dystrophin loss, but a secondary effect resulting from dystrophic 
muscles increased incidence of degeneration and regeneration. I performed 
further experiments to address whether myofiber damage itself was indeed 
causing the observed changes in NMJs. 
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3.3.2. Mdx dynamic junctions show morphological differences compared to stable 
junctions  
When morphological measurements of the NMJ were compared between 
dynamic and stable endplates of mdx mice, subtle but significant differences 
were observed. As described in Section 2, pre- and postsynaptic morphologies 
were analyzed. This included measurements of junctional area, receptor area, 
fragmentation, DI, number of  motor axon branches, and number of tSCs. At 
P38, the DI of dynamic endplates showed greater spread of the AChR at dynamic 
junctions (stable = 0.3725 ± 0.02, dynamic = 0.3069 ± 0.016, t(25) = 2.261, P = 
0.0327, t-test). The same trend was evident at P66 (stable = 0.3738 ± 0.013, 
dynamic = 0.3098 ± 0.028, t(44) = 2.169, P = 0.0216, t-test). Additionally, at 
P66, dynamic junctions had a lower receptor area than stable junctions (stable = 
508.4 ± 34.21, dynamic = 304.4 ± 36.33, t(44) = 3.246, P = 0.0009, t-test). No 
other attributes measured were significantly different between dynamic and 
stable junctions. As mentioned before at P66, almost all endplates were 
fragmented. These results suggested that not only can myofiber degeneration and 
regeneration cause a morphological shift from continuous to fragmented, but also 
that an already fragmented endplate can rearrange further following additional 
rounds of myofiber degeneration and regeneration. Continued remodeling may 
explain the changes in DI, junctional area, and fragmentation in older mdx 
animals in Section 2. While not measured, there were no obvious receptor 
clusters in mdx that were not covered by axon terminals. This corresponds well 
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with our hypothesis and previous work showing that nerve terminal 
rearrangement following myofiber regeneration is responsible for endplate 
remodeling (Li and Thompson, 2011). In other words, the nerve likely grows and 
branches along the myofiber, and directs new sites of receptor accumulation, in 
non-continuous islands. The regenerating muscle does not first deposit AChRs, 
which the nerve then innervates. 
 
3.3.3. Fiber damage at the endplate region of the muscle causes increased receptor 
replacement, in both mdx and WT animals 
In order to test whether dynamic junctions are indeed a result of myofiber 
degeneration and regeneration, the same two-color BTX method was performed in 
conjunction with deliberate injury of the STM. Briefly, after the BTX-1 label was 
applied, a superficial cut was made across the muscle with a scalpel near the endplate 
region to spur myofiber necrosis. The contralateral muscle was also labeled, but not 
injured, and used as an IC. When this was performed in P38 WT animals, the proportion 
of dynamic junctions in damaged muscles was 19.1x that of the IC (Figure 3.6A. P38 
t(6) = 3.111, P = 0.0208. t-test). In P66 WT animals, the proportion of dynamic junctions 
in damaged muscles was 31.6x as large as IC. (Figure 3.6A. P66, t(6) = 3.963, P = 
0.0074, t-test). When deliberate injury was performed at the endplate area in P38 mdx, 
the proportion of dynamic junctions in damaged muscle was 1.7x as large as that of the 
IC, and at P66 the proportion of dynamic junctions in damaged muscle was 2.1x as large 
as the IC (Figure 3.6A. P38 t(6) = 3.013, P = 0.0236; P66 t(6) = 3.772, P = 0.0093, t-
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test). This showed that myofiber damage near the endplate area was sufficient to induce 
increases in AChR replacement in both WT and mdx mice. A full accounting of 
significant differences in NMJ characterization can be found in A-3 and A-4. 
Injury made near the sternum, as far as possible from the endplate band of 
the STM, did not result in significant increases in the amount of receptor 
replacement in either WT or mdx animals at either P38 or P66 (t-test, df = 6.  
n.s.). This suggests that damage to the muscle must be in the vicinity of the NMJ 
to elicit increases in receptor replacement associate with mdx. Myofiber damage 
in the mdx model likely does not propagate down the entire muscle fiber 
following a single insult. The long chains of central nuclei result not from a 
single catastrophic event, but the accumulation of many smaller events of 
segmental necrosis and regeneration in the myofiber. Our model of assessing 
myofiber damage and regeneration, however, was focused on the NMJ.  
Therefore, I could not assess the segmental nature of damage and can only 
suggest it does not travel down the myofiber. 
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Figure 3.6. NMJ receptor replacement and categorization following myofiber cut.  
(A) Receptor replacement following myofiber injury in WT and mdx STM. Both WT and mdx mice 
showed increases in receptor replacement following damage as assessed by percentage of dynamic 
junctions. Asterisks denoted significant differences (t-test, * 
P < 0.05, ** P < 0.001). (B) NMJ categorization following myofiber injury in P38 WT and mdx. 
Following muscle injury, the proportion of dynamic, fragmented junctions was significantly 
increased and the proportion of stable, continuous junctions was decreased compared to ICs in both 
WT and mdx animals (2-Way ANOVA, Bonferroni post- hoc test, P < 0.001). Bars below the graphs 
indicate significant differences in the proportion of junctions within IC or damaged groups (2-Way 
ANOVA, Bonferroni post-hoc test, P < 0.05), while dashed lines above the graphs indicate 
significant differences between the two groups (2-Way ANOVA, Bonferroni post-hoc test, P < 
0.001). Not all significant differences within genotypes are shown for sake of brevity. (C) Increases 
in receptor replacement following myofiber damage in WT and mdx. After damaging the STM, WT 
and mdx animals had similar increases in receptor replacement. This was true for both P38 and P66 
animals (t-test, n.s.). This result was interpreted to mean that WT and mdx animals had similar 
degenerative and regenerative responses to cut damage near the endplate, and that the magnitude of 
our injury was constant. Exact n can be found in text as t(df) = t-value. n = df + 2. n is the number of 
mice compared. In all graphs, dots represent individual data points 
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In an effort to more closely mimic damage that would occur in the mouse, I also 
performed a similar experiment using a crush injury. In this paradigm the basal lamina 
surrounding the myofibers should be left generally intact. This is similar to how damage 
due to muscle contraction in dystrophy leaves the basal lamina intact, while 
macrophages phagocytize the myofiber. The regenerating myofiber then grows and 
matures within the basal lamina sheath. Similar results compared to the cut experiments 
were observed in crushed mdx muscle, but not WT muscle. Receptor replacement was 
not elevated in WT crushed muscles at P38 when compared to IC (Figure 3.7A), but was 
increased at P66 (t(6) = 6.716, P = 0.0005, t-test). On the other hand, mdx muscles at 
both ages displayed increases in receptor replacement in crushed muscles. Mdx muscle 
receptor replacement was 2x larger than IC at P38 (t(6) = 3.089, P = 0.0214, t-test) and 
P66 (t(6) = 4.453, P = 0.0043, t-test). When the magnitude of response to crush damage 
was compared between WT and mdx, P38 mdx animal’s receptor replacement increase 
was 3.3x that of WT (Figure 3.7B, t(6) = 2.668, P = 0.0371, t-test).  
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Figure 3.7. NMJ receptor replacement following myofiber crush. 
(A) Receptor replacement following myofiber crush in WT and mdx STM. At P66 both WT and 
mdx mice showed increases in receptor replacement following damage, as assessed by 
percentage of dynamic junctions. Asterisks denote significant differences (t-test, *P < 0.05, ** P 
< 0.01, *** P < 0.001). (B) Increases in receptor replacement following myofiber damage in WT 
and mdx. After crushing the P38 STM, mdx animals responded to a greater degree than WT in 
terms of changes in receptor replacement (t-test, P < 0.05). This was not evident for both P66 
animals. (t-test, n.s.). It is possible that due to the small size of the muscle at P38, the crush was 
closer to the endplate area at this age and mdx animals responded to a greater degree, as 
suggested by the relative frequency analysis in (A). Exact n can be found in text as t(df) = t-
value. n = df + 2. n is the number of mice compared.  
 
 
Taken together, I show here that muscular dystrophy in mdx mice causes 
increases in AChR replacement as NMJs remodel. This increased AChR 
replacement is due to myofiber degeneration and regeneration at the synaptic site 
and is correlated with abnormal endplate morphology. Still, the degeneration and 
regeneration causing NMJ remodeling is a byproduct of muscular dystrophy and 
the loss of dystrophin protein at those NMJs, as muscle damage away from the 
junction caused no significant increases in AChR replacement.  
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3.3.4. The innervating motor axon is necessary for remodeling to occur following 
receptor replacement 
I next investigated the role that the innervating motor axon plays in receptor 
replacement and endplate remodeling in mdx mice. It has previously been 
suggested in mdx mice that the nerve is necessary to restructure the endplate 
upon muscle cell regeneration (Marques et al., 2007). However, in this 
experiment whether or not the endplate area of the muscle was injured could not 
be directly assessed. To investigate the role of innervation in remodeling specific 
to regenerated NMJs, the two-color BTX approach was again utilized, but the 
nerve that innervates a single STM (accessory nerve) was severed at the time of 
the first BTX exposure. After the 10-day convalescent period the nerve had not 
regrown to the endplate region and no NMJs were innervated (Figure 3.8A). The 
contralateral muscle was left innervated as an IC. The procedure was initiated in 
P28 mice. Again, at the endpoint of this experiment (P38) there are still a large 
number of junctions that were not fragmented in mdx mice, so I am able to 
record changes in the proportion of fragmented or continuous junctions with and 
without the nerve. Receptor replacement in denervated mdx muscles was 
elevated above those of ICs (Figure 3.8B. t(6) = 3.227, P = 0.018, t-test). This 
was somewhat surprising. Denervation and/or blocking muscle contractions is 
known to promote AChR replacement (Loring and Salpeter, 1980; Akaaboune et 
al., 1999), but it does not change the half-life of mdx AChRs (Xu and Salpeter, 
1997). It is likely that increases in receptor replacement were due to both 
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myofiber damage at the endplate area, and denervation induced changes to 
receptor half-life. The total loss of receptors denoting dynamic junctions, 
however, is not a feature seen even in chronically denervated NMJs. 
In comparison to innervated muscles, denervated P38 mdx STMs had an 
increase in the number of dynamic, continuous junctions (Figure 3.8C. t(6) = 
5.484, P < 0.001, 2-Way ANOVA, Bonferroni post-hoc test) and a corresponding 
decrease in dynamic, fragmented junctions (Figure 3.8C. t(6) = 3.684, P < 0.01, 
2-Way ANOVA, Bonferroni post-hoc test). This indicates that following receptor 
replacement—as denoted by dynamic junctions—the nerve must be in contact 
with the endplate area to cause NMJ remodeling.  
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Figure 3.8. Innervation is required for NMJ remodeling in P38 mdx mice. 
(A) Confocal maximum intensity projection of P38 mdx innervated (IC) and denervated STMs. “#” 
denotes dynamic, fragmented junctions. Asterisks denotes dynamic, continuous junctions. In the 
composite image BTX-1 has been pseudocolored red, BTX-2 green, and motor axon cyan. Note that in the 
denervated muscle there is no motor axon labeling in the maximum intensity projections. This indicates 
motor axon loss and no regeneration during the 10-day recovery period. Additionally, both the IC and 
denervated collections have NMJs with little or no BTX-1 label. This indicates AChR replacement 
attributed to myofiber degeneration/regeneration or increased in receptor half-life due to denervation in 
both NMJs with and without innervation. Scale bar = 20 µm. (B) Receptor replacement in P38 mdx 
following denervation. Receptor replacement, as assessed by dynamic junctions, is elevated in P38 mdx 
denervated muscles as compared to IC (t-test, P < 0.05). (C) NMJ categorization in P38 mdx mice after 
denervation. Following denervation, the proportion of dynamic, fragmented junctions is significantly 
decreased, and the proportion of dynamic, continuous junctions is decreased compared to non-denervated 
IC (2-Way ANOVA, Bonferroni post-hoc test, P < 0.001). Bars below the graphs indicate significant 
differences in the proportion of junctions within IC or denervated groups (2-Way AVOVA, Bonferroni 
post-hoc test, P < 0.05), while bars above the graphs indicate significant differences between the two 
groups (2-Way ANOVA, Bonferroni post-hoc test, P < 0.001). Not all significant differences within 
genotypes are shown for sake of brevity. This information can be found in A-5. Exact n can be found in 
text as t(df) = t-value. n = df + 2. n is number of mice compared.  
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3.4. Discussion 
While many have postulated that the NMJ changes in mdx animals are due to myofiber 
damage, there has been little direct investigation of the link between these phenomena. 
Other investigators have correlated central chains of nuclei within a myofiber to 
fragmented junctions (Lyons and Slater, 1991), but it is unclear if central nuclei are a 
marker for recent myofiber regeneration. Historically, myofibers with nuclei in the 
center of the cytoplasm, instead of the periphery, have been used to identify regenerated 
muscles (Benoit and Belt, 1970). Unfortunately, this method of investigating 
regeneration has its drawbacks. For one, the time course over which myonuclei move 
from the center to the periphery of the fiber may be very long and not indicate truly 
recent regeneration (Wada et al., 2008). In vivo two-color BTX labeling made it possible 
here to identify recently regenerated muscle fibers and to categorize their NMJs by 
morphology. This approach has allowed the detection and quantification of dynamic 
junctions in normal, dystrophic and damaged muscle and our results indicate that recent 
myofiber degeneration and regeneration cycles leading to NMJ remodeling involves 
significant replacement of AChRs. 
Two-color BTX experiments demonstrated that myofiber degeneration and 
regeneration is continuously elevated in mdx STM from P38 to P450. This finding 
contradicts previous reports that have described the pathology of mdx muscles as 
transitioning from an early necrotic stage at 3 weeks, to a regenerative state that closes at 
12 weeks (DiMario et al., 1991). However, it must be mentioned that the STM was not 
investigated in these reports. Using tritiated thymidine and investigating satellite cell 
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nucleus incorporation into myofibers, an elevated level of myofiber regeneration in mdx 
was shown to be restricted to an acute period from P24 to P50. A chronic phase of 
myopathy follows with a much lower level of labeled nuclei (McGeachie et al., 1993). A 
similar observation of an early crisis period in mdx mice has been described by 
researchers via embryonic myosin expression and histological methods (DiMario et al., 
1991; Pastoret and Sebille, 1995). However, other reports suggest that myofiber damage 
may still be vastly elevated past this crisis period (Coulton et al., 1988a; Pagel and 
Partridge, 1999). The results of the two-color BTX investigation hold with the latter 
conclusion. If the loss of the first BTX label is indeed due to myofiber necrosis at the 
synaptic site, then our results demonstrate that the degenerative and regenerative cycle of 
dystrophic muscle fibers extends well into the adult life of mdx STMs. I did, however, 
find evidence of an early life crisis period in mdx TA, as has been suggested by other 
researchers (Dangain and Vrbova, 1984). It is possible the differences in the incidence of 
receptor replacement, and therefore damage, in the different muscles is based on use. 
The STM is a neck muscle that is used in the feeding behavior of these mice. The TA is 
a hindlimb muscle used in movement, but these mice are housed in small cages and 
likely have a more sedentary lifestyle than would normally been seen, and mdx animals 
are also less active than WT (Hara et al., 2002). It is established the exercised mdx mice 
have higher rates of muscle damage and different pathological outcome than WT 
(Dupont-Versteegden and McCarter, 1992; Brussee et al., 1997).  
Our results also show it is unlikely that the dystrophin loss itself causes increased 
receptor replacement, but such replacement is rather due to myofiber damage resulting 
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from the loss of the protein. Deliberate damage to muscle fibers in WT mice resulted in 
similar receptor replacement and NMJ remodeling as seen in mdx muscles. While there 
are reports of clustering abnormalities in myotubes in vitro lacking dystrophin (Kong 
and Anderson, 1999), AChRs clusters in mdx mice develop normally into a pretzel-
shaped morphology early in life. It is only after the onset of myofiber necrosis at P21 
that remodeling begins to occur. This suggests that myofiber damage is causative in 
NMJ remodeling in mdx mice. It has been shown that in other mouse models NMJ 
remodeling can occur without myofiber damage (Kong et al., 2012; il Lee et al., 2016). 
However, deliberate injury to the fibers near their endplates increased NMJ remodeling 
in mdx muscles.  
The half-life of AChRs in healthy, innervated NMJs is about 14 days 
(Akaaboune et al., 1999). It has also been shown that there are different pools of AChR 
with distinct half-lives, the shortest being about 1-day (Strack et al., 2011). However, 
even when similar in vivo two-color BTX techniques are used in NMJs where metabolic 
receptor turnover was increased through long term denervation (Strack et al., 2011), the 
catastrophic loss of the first BTX label was not observed, as I see in dynamic junctions. 
This I believe shows the reliability of our measurements, and that dynamic junctions do 
indeed represent myofiber degeneration and regeneration. Again, while some loss of 
BTX-1 would be expected even in WT animals, the exaggerated, almost complete loss of 
receptors from dystrophic muscles over a 10-day period is abnormal. It must be noted 
that in the experimental procedure where fibers had been deliberately damaged, those 
injured fibers could not be relocated when imaged. I am, therefore, unable to definitely 
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link myofiber damage and dynamic junctions. Previous investigation, however, has 
shown that when deliberately damaged muscles are imaged over time NMJs become 
dynamic (Li and Thompson, 2011). It is possible that receptor replacement is not 
occurring on damaged myofibers, but on fibers subjected to disuse or inflammatory 
response. An effort, of course, was made to recover muscle fibers in the area of damage, 
but this cannot be guaranteed. 
Increased AChR replacement has been observed at NMJs whose receptors have 
been blocked by a sufficiently high dose of BTX to cause neuromuscular transmission to 
fall below the threshold necessary for the generation of muscle action potentials. 
However, in these experiments, a sufficiently low concentration of BTX that does not 
accelerate the replacement of receptors was used to allow continued transmission, and to 
not perturb morphology (Akaaboune et al., 1999).  
The STM and TA were chosen for examination in these experiments, largely 
because of their accessibility for BTX application and for in-vivo labeling. It is clear that 
different muscles in muscular dystrophy are affected to different degrees. For example, 
one of the muscles most affected in murine dystrophy is the diaphragm (Stedman et al., 
1991; Petrof et al., 1993), while the extraocular muscles and small caliber muscle fibers 
might be spared (Karpati et al., 1988; Porter et al., 2003). The diaphragm exhibits signs 
of constant degeneration and subsequent fibrosis and adipose tissue deposition unlike 
many other muscles studied in the mouse. This likely is due to the amount of activation 
(and damage) to which the diaphragm is subjected via contractions during respiration. A 
similar phenomenon may be occurring in the STM of mdx mice. It is documented that 
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the trunk and neck muscles of neonatal GRMD dogs are more severely affected than 
appendicular muscle groups (Nguyen et al., 2002a), likely because they are postural 
muscles and they are used more constantly than muscles involved with movement, and 
therefore subjected to increased contraction induced damage. Atrophy of the truncal 
muscles has been noted in older animals as well (Valentine et al., 1988). The STM has 
not been typically investigated in dystrophy. While it would be interesting to use the 
two-color BTX approach in the diaphragm of mdx animals, such an experiment would 
be difficult, due to accessibility issues. As mentioned previously, however, experiments 
in the TA hinted that myofiber damage was restricted to a crisis period. 
The innervating motor axon terminal plays a role in remodeling of the AChRs at 
the synapse after muscle injury (Li and Thompson, 2011) and has been implicated in  
dystrophy (Marques et al., 2007). Our investigation was able to examine individual 
myofibers and synaptic sites that have recently undergone replacement due to myofiber 
necrosis. In the absence of the nerve, the receptors are still lost from the membrane, but 
upon regeneration the morphology is continuous. It also suggests that mdx muscle 
damage can occur without transmission induced contraction, possibly due to preexisting 
fenestrations in the sarcolemma. Excepting denervation-induced fibrillation (Purves and 
Sakmann, 1974; Thesleff and Ward, 1975), it is unlikely that denervated muscles 
experience much contractile activity. Another explanation of BTX-1 loss in denervated 
STM is that immediately prior to denervation, or perhaps during the surgery, the muscle 
fiber was damaged and may have begun the process of necrosis. I hypothesize that in 
mdx mice, myofiber damage caused by lack of dystrophin leads to degeneration and 
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regeneration of the muscle fiber and this is the first step in the cascade of events that 
leads to NMJ rearrangement. Fragmentation and remodeling of the NMJ is a response to 
muscle fiber regeneration that follows the degeneration of muscle cells. It is not that the 
old NMJ is losing receptor sites due to patches of membrane degradation During 
regeneration, the innervating motor neuron axon, which remains on the basal lamina at 
the synaptic site of the damaged myofiber, sends out “sproutlets” and varicosities to 
search for the regenerating fiber (Li and Thompson, 2011). As the fiber regenerates, new 
AChRs are inserted into the sarcolemma at areas that are contacted by these varicosities 
and sproutlets. This causes a fragmented appearance on the postsynaptic AChR 
aggregate. If the motor axon is not present, when the myofiber regenerates, the AChR 
aggregate will remain in its original morphology. That is to say if the aggregate was 
previously continuous it will remain continuous upon myofiber regeneration. I show that 
the innervating motor axon is responsible for NMJ fragmentation, a hallmark of the 
dystrophic endplate. Without direction from the axon, NMJ remodeling does not occur. 
It is possible that factors like agrin released from the sproutlets result in the fragmented 
distribution of AChR. 
A confounding attribute to the denervation experiments is that in the absence of 
innervation, myofibers undergo atrophy (Pellegrino and Franzini, 1963; Bodine et al., 
2001). The increases in the number of continuous junctions may be a result of myofiber 
collapse. It is possible that the junctions do in fact restructure themselves 
morphologically even in the absence of neural input, but upon subsequent myofiber 
atrophy the fragments connect with each other. From the parameters this report and 
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others use to define fragmented (i.e. having 5 or more non-continuous clusters of AChR) 
versus continuous junctions, this remodeling might not have been realized. Whether the 
sparing of morphological change has any physiological consequence remains to be 
investigated.  
 Neuromuscular transmission properties of remodeled endplates in dystrophy 
should be closely investigated. There are a number of published studies that have 
researched the functionality and electrophysiology of dystrophic NMJs. However, the 
results are often contradictory, especially when miniature endplate potential (mEPP) 
amplitude and variability are investigated (Nagel et al., 1990; Lyons and Slater, 1991; 
Carlson and Roshek, 2001; van der Pijl et al., 2016). This could be due to the differences 
in experimental methods, or perhaps to the variability of the disease state and its 
progression, or even the muscles used. Researchers have shown that in aged NMJs, 
which have a similar morphology to dystrophic and damaged NMJs, there is little 
difference between normal and remodeled junction physiology (Willadt et al., 2016). In 
fact, the fragmented morphology may increase the efficiency of transmission. Whether 
or not this is the same for dystrophy remains to be clearly elucidated, but some 
experiments on the physiology of such junctions indicate an absence of major defects 
(Lyons and Slater, 1991), while others show obvious deficiencies in neuromuscular 
transmission (Personius and Sawyer, 2006). However, the current study shows the 
changes in junction morphology are progressive, in that remodeled junctions can likely 
further remodel. It is possible that significant changes in the physiology of 
neuromuscular transmission do appear in the later stages of the disease. Interestingly, in 
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DMD patients and clinically relevant animal models, such as GRMD, there is evidence 
of neuromuscular transmission deficiencies (Hilton-Brown et al., 1985; Sanders and 
Stålberg, 1996; Kornegay et al., 2012).  
This study and others have shown that changes to the structure of the NMJ occur 
rapidly and irreversibly. Present treatments for DMD do not commonly begin until after 
the onset of the disease at which time changes to the morphology of the NMJ have 
already occurred. I believe it is important to study the remodeling of the NMJ as 
mitigation of this remodeling might alter the progression of the disease. This would 
especially be the case if remodeled junctions are physiologically deficient. Animal 
models are necessary for this sort of investigation, as the in vivo nature and invasiveness 
of the research prevent humans from being subjects. This study demonstrates that the 
sequence of events that lead to altered NMJs is dependent upon the motor neuron, but 
initiated by muscle damage. I suggest that an additional component to treatment of the 
disease besides sparing of muscle degeneration may be altering the changes that occur in 
muscle innervation.
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4. FUNCTION OF DYSTROPHIC MUSCLE AND CARDIAC TISSUE THROUGH 
DISEASE PROGRESSION 
 
4.1. Research impetus 
While the force generation characteristics of mdx muscles have been characterized, there 
are only a handful of articles detailing neuromuscular performance of dystrophic NMJs 
(Nagel et al., 1990; Carlson and Roshek, 2001; Personius and Sawyer, 2006; van der Pijl 
et al., 2016; van der Pijl et al., 2018). These articles on the mdx model noted slight 
changes to neuromuscular transmission in the diaphragm, which includes variability in 
synaptic transmission (i.e., MEPP amplitude) and quantal content. While the diaphragm 
is characterized as the most affected muscle in mdx disease progression, I have shown 
(Sections 2 and 3) that the STM incurs a constantly elevated level of muscle 
degeneration and regeneration. It is possible then that this muscle, in comparison to limb 
muscles, also displays neuromuscular transmission deficits, perhaps to an even greater 
degree. These differential changes in disease impact may be due to NMJ remodeling and 
present a potential therapeutic target strategy to ameliorate dystrophic pathology. 
Additionally, as NMJ remodeling is progressive, it is possible that at later stages of the 
disease, NMJ dysfunction will be more evident.  
 As supportive treatments for DMD have advanced, specifically for respiratory 
issues, the main cause of mortality in patients shifted from respiratory failure to cardiac 
complications due to dilated cardiomyopathy (Eagle et al., 2002; McNally, 2007). This 
deadly heart compromise does not occur until later stages of the disease in most young
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men, well past when skeletal muscle first weakens. A similar cardiomyopathy has been 
noted in mdx mice, but rigorous studies have not been performed in geriatric mdx mice. 
Echocardiography, a noninvasive technique used extensively in DMD patients, was 
adapted for use in both conscious and unconscious mdx mice near the end of their lives 
(16+ months). I investigated if cardiac function in geriatric dystrophic mice  becomes 
significantly worse as compared the heart function in WT and younger mdx mice. I 
observed few significant changes in cardiac function between these groups.  
 
4.2. Materials and methods 
 
4.2.1. Geriatric skeletal muscle 
 
4.2.1.1. Animals 
Mice were generated as in Section 2.1.2.1. Animals were divided into four groups: WT 
mice (ages 3 – 7 months), mdx crisis (< 12 weeks old), mdx stable ( 12 weeks - 16 
months old), and mdx geriatric (> 16 months). Muscles were collected from 3 – 7 mice 
for each group, for a total of 29 mice. 
 
4.2.1.2. Mouse muscle preparation 
Mice were euthanized via I.P. injection of 0.15 mL of Euthasol. The STM was 
dissected, pinned at resting length to a sylgard dish and fixed using 4% 
phosphate buffered PFA for 20 minutes. After fixation, the muscles were washed 
  
100 
 
three times with phosphate buffered saline (PBS) and labeled with α-
bungarotoxin conjugated to Alexa FluorTM 555 or Alexa FluorTM 647 
(ThermoFisher Scientific, Cat# 35450) for 5 minutes at a concentration of  2 
µg/mL of PBS. DAPI (Thermo Fisher Scientific Cat# D3571, 
RRID:AB_2307445) was used to label nuclei (diluted 0.5 µg/mL in PBS). After 
three PBS washes, a longitudinal filet from across the surface of the muscle was 
dissected from distal tendon to proximal tendon and mounted on a microscope 
slide in anti-fade fluorescence mounting medium.  
 
4.2.1.3. Image analysis 
Confocal micrographs of labeled STM were collected on either a Leica TPS II SP5 or a 
Zeiss LSM780 microscope using a 40X Oil objective (NA 1.4). Step size was set 
between 300-500 nm. Laser lines 488 nm, 563 nm, and 633 nm were used as necessary. 
Images were analyzed in ImageJ (ImageJ, RRID:SCR_003070) by creating maximum 
intensity projection images from collected stacks. Junctional area was calculated by 
thresholding the BTX labeled channel using the Auto Threshold tool provided by 
ImageJ. A polygon shaped region of interest was then circumscribed around the 
thresholded signal and the region of interest’s area measured. Receptor area was 
measured as the thresholded area of the BTX label within the circumscribed region of 
the AChR. Dispersion Index was calculated as receptor area/junctional area. The number 
of AChR fragments (fragmentation) was measured using the objects counter in ImageJ 
by setting the minimum area for counts as 5 µm2. As this measurement does not consider 
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fragments in separate z-planes, it is a conservative estimate of fragmentation. The actual 
number of fragments for both WT and mdx is likely underestimated by this 
measurement.  
 
4.2.1.4. Force recordings 
Animals were weighed and the EDL, SOL, and STM were removed from animals from 
tendon to tendon with the associated peripheral nerve attached. Proximal tendons were 
attached to a piece of bone to provide an anchor for pinning. Due to fragility of EDL and 
STM distal tendons, an 8-0 surgical thread was tied around them. For the STM a loop 
was tied into the thread. Muscles were superfused with oxygenated Ringer’s solution 
both during dissection and force recordings. Muscles were pinned to a sylgard dish via 
their proximal bone section, and to a hook force transducer (Harvard Apparatus, 
Massachusetts, USA) through their distal tendon. For STM, the hook was attached to the 
loop, while for EDL and SOL muscles, the attachments were made directly to the 
tendon. Optimum length of muscles was determined by delivering suprathreshold pulses 
to the nerve and stretching the muscle until no increases in force were noted. Isometric 
twitch forces were generated via a single suprathreshold (10-20 V) pulse (Grass 
Instruments). Direct stimulation (150 V) was delivered to the muscle through two 
titanium plates surrounding the muscle near its midsection. Indirect stimulation was 
delivered to the nerve via a suction electrode into which the attached nerve was inserted 
along with oxygenated Ringer’s. Tetanic force was generated by 60 Hz stimulation for 2 
s. Again, direct and indirect stimulation were applied to the muscle.  
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 The twitch and tetanic force recordings were displayed on a Tektronics DPO 
2024 oscilloscope (Oregon, USA) and maximal responses were measured from the 
traces following both direct and indirect stimulation. Fatigability of the muscles during 
tetanic stimulation was measured as the percent of maximum tetanic force retained from 
near the beginning of tetany to the force generated at the end of the 2 s train. To 
normalize measurements by body size, the force generated during stimulation was 
divided by the animal’s body mass. NMJ performance was estimated as the ratio 
between indirect stimulation and direct stimulation for twitch and tetanic force, and the 
fatigability of muscle during indirect over direct tetanic stimulation. The SOL and/or 
EDL and/or STM were removed from the mouse and recorded from. Three to 7 of each 
muscles were recorded from in each genotype/age (WT, mdx crisis, mdx stable, mdx 
geriatric). 
 
4.2.1.5. Statistics 
NMJ morphology measurements were compared to those preceding them in age 
using a 1-Way ANOVA with a Sidak’s post-hoc test (Graphpad, PRISM 7.0). Statistical 
significance was placed at P = 0.05. Significant or of interest P-values and degrees of 
freedom are recorded in text. 
Muscle force recordings were compared to one another within groups using a 2-
Way ANOVA with a Tukey’s post-hoc test (Graphpad, PRISM 7.0). Statistical 
significance was placed at P = 0.05. Significant or of interest P-values and degrees of 
freedom are recorded in text. 
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4.2.2. Geriatric cardiac muscle 
 
4.2.2.1. Animals 
Mice were generated as in Section 2.1.2.1. Animals were divided into four groups. WT 
young (< 6 months), WT geriatric (> 16 months), mdx young (< 6 months old), and mdx 
geriatric (> 16 months). 3-5 mice per group were used for a total of 17 mice. 
 
4.2.2.2. Echocardiography 
The chest of the animals was depilated and covered in ultrasound jelly. For unconscious 
mice, the animals were incubated in a flow chamber delivering 4% isoflurane at a flow 
rate 1L/min. Following full anesthetization, mice were placed on a surgical platform and 
1.5% isoflurane was delivered via a face mask for maintainence. B-Mode (which 
provides a 2D view of the heart), and M-Mode (which provides motion data across a 
single ultrasound beam in a wave form) echocardiograph images and videos of the left 
ventricle were collected using a Vevo 3100 (Visual Sonics, Ontario, Canada) with a 30 
MHz probe. B-Mode parasternal long axis and M-mode parasternal short axis images 
were collected in unconscious mice. Myocardial strain was analyzed using B-mode 
videos. Following a 2-day recovery period, the same procedure was conducted in a 
conscious state. Conscious mice were restrained via scruffing, and care was taken to 
collect echocardiographs as quickly as possible to reduce stress to the animal. 
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4.2.2.3. Echocardiography analysis and statistics 
Collected images and movies were analyzed in VevoLab or VevoStrain software (Visual 
Sonics, Ontario, Canada). VevoLab was used to analyze the M-mode collections and 
standard echocardiograph measurements of the left ventricle. These included 
morphological measurements, such as diastolic and systolic diameter and volume, and 
functional measurements such as ejection fraction (end systolic volume – end diastolic 
volume/end diastolic volume x 100), fractional shortening (end systolic diameter - end 
diastolic diameter/end diastolic diameter x 100), stroke volume (end diastolic volume – 
end systolic volume), cardiac output (stroke volume x heart rate), and heart rate. 1-Way 
ANOVA with Tukey’s post-hoc test was used to compare groups to each other. 
Significance was set at P < 0.05.  
 Using VevoStrain software, B-mode long axis videos of the left ventricle were 
used to analyze strain and desynchrony of contraction. Strain was measured both radially 
and longitudinally using speckle tracking, a technique that uses the noise inherent in 
echocardiography images to analyze the elasticity of cardiac tissue. The 
endomyocardium was used as the reference for all strain analysis and the left ventricle 
segmented into 6 parts: posterior apical, posterior mid, posterior basal, anterior apical, 
anterior mid, and anterior basal. Peak global longitudinal strain and delay in peak global 
longitudinal strain between opposing walls were compared using a 1-Way ANOVA with 
a Tukey’s post-hoc test. Segmental strain (both longitudinal and radial) were compared 
using a 2-Way ANOVA with a Tukey’s post-hot test. Unless otherwise noted, graphs 
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display mean and standard error. Statistical analyses were performed in GraphPad Prism 
7.0 (GraphPad Software, San Diego, USA). 
 
4.3. Results 
 
4.3.1. Geriatric mdx skeletal muscle 
 
4.3.1.1. NMJs of geriatric mdx mice are further remodeled 
When the morphology of geriatric mdx NMJs is compared to younger mdx mice, it is 
clear that remodeling of the synapse is an ongoing process that continues through the 
mdx crisis period, stable ages, and into near death, geriatric ages (Figure 4.1; P66, crisis; 
P450, stable; >16 months, geriatric). The postsynaptic apparatus was subjected to the 
same measurements previously outlined in Section 2. However, these measurements fail 
in some regards to describe the vast changes seen in the geriatric mdx NMJs. 
Observationally, the neuromuscular synapses of these very old animals can be divided 
into two distinct populations. One population takes on the fragmented appearance noted 
in all mdx animals past the onset of muscle damage at P21 (Figure 4.1; geriatric mdx). 
The other NMJ population has a vastly different appearance, where receptor clusters are 
neither continuous nor islands, but rather the endplate is granular and disintegrated 
(Figure 4.1; geriatric mdx). In fact, these geriatric NMJs resemble the BTX-1 label of 
dynamic junctions observed in younger mdx animals and those of experimentally-
induced muscle damage at the synaptic site (Section 2). The geriatric fragmented and 
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granular junctions indicate that NMJs in mdx further remodel past the P450 time point, 
likely due to the accumulation of myofiber damage. 
When the postsynaptic morphology of geriatric mdx NMJs are compared to those 
preceding them in age, a significant amount of remodeling can be appreciated (Figure 
4.2). Junctional area, which increases 135% from in P66 mdx crisis NMJs to the P450 
mdx stable NMJs (P = 0.002, df = 119, Sidak’s multiple comparison test), actually 
decreases 43% in mdx geriatric NMJs from P450 junctions (P = 0.0126, df = 119, 
Sidak’s multiple comparison test). Fragmentation was also found to exhibit an early 
increase of 64% followed by a decrease of 47% in mdx geriatric NMJs (P66 to P450: P = 
0.002, df = 119; P450 to geriatric: P < 0.001, df = 119, Sidak’s multiple comparison 
test). Although a similar trend existed for receptor area, only the increases P66 to P450 
were statistically significant (P = 0.0445, df = 119, Sidak’s multiple comparison test). 
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Figure 4.1. Geriatric mdx NMJs are further remodeled from those of adult mdx NMJs.  
Confocal images of geriatric mdx NMJs in STM muscle. There are two populations of NMJs one that is fragmented in 
appearance (arrow) and one that is granular (arrowhead). P66 animals are within the time frame of the proposed crisis 
period, which does not occur in the STM, but does in the TA and likely other limb muscles. P450 animals and 
geriatric animals are well outside the proposed crisis period (3-12 weeks). Geriatric mdx images are from an animals 
over 19 months of age. Most junctions appear to be fully or partially innervated. In composite images AChR is 
pseudocolored red, and axons cyan. Scale for all images is 20 µm. Note the change is scale in the lowest row.  
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No differences were detected for DI. Again, these measurements indicate that 
NMJ remodeling continues to occur in the STM even at the end-stage of the disease and 
may result in decreased muscle function in diseased geriatric mice. In previous sections, 
I have described how the process of NMJ remodeling in younger animals is dictated by 
myofiber degeneration and regeneration, and is regulated, directly or indirectly through 
tSCs, by the motor axon. It is probable that the same phenomenon is occurring in the 
STM of geriatric STMs. However, this continued remodeling process involves 
disintegration of the NMJ’s AChR cluster fragments and granularization of the 
remaining receptors. By and large, the granularized junctions appeared to be innervated, 
but this was not a measurement that was actively made. In some cases, faint axonal 
labeling was apparent and may have been a result of NMJ position in the tissue sample. 
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Figure 4.2. Mdx NMJs continue to remodel with into geriatric ages. 
Postsynaptic measurements of mdx NMJs in STM from P38 to geriatric ages.  
1-Way ANOVA with Sidak’s post-hoc test. Groups were only compared to those that 
immediately preceded them in age (i.e. P66 to P38, P450 to P66, and geriatric to P450). 
Asterisks denote significant differences (* < 0.05, ** < 0.01, *** < 0.001, **** < 0.001) 
 
 
4.3.1.2. Geriatric mdx muscle have decrements in force production 
Geriatric mdx NMJs continue to remodel as they age (Figure 4.2). However, whether or 
not these further changes in synaptic structural organization impart functional 
consequences is unknown. To address this question, the force generation characteristics 
of EDL, SOL, and STM muscles were compared across ages to measure if evoked 
contraction properties of geriatric mdx muscles declined as they continued NMJ 
remodeling with age (Figure 4.3). Electrical current was delivered to both the muscle 
directly, and also indirectly to the motor nerve to elicit isometric muscle contractions. 
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For EDL and SOL muscle contractions few changes in direct twitch force or indirect 
twitch force were noted for any groups (WT, mdx crisis, mdx stable, mdx geriatric). 
Maximum tetanic force generated by SOL muscles of mdx crisis group were 
significantly smaller than those of mdx stable muscles (P = 0.0213, df = 35, 2-Way 
ANOVA, Tukey’s post-hoc test). In mdx crisis STM muscles, where they produced less 
force during indirect tetanus than mdx stable muscles (P = 0.0264, df = 37, 2-Way 
ANOVA, Tukey’s post-hoc test). More relevant to these aging studies, mdx geriatric 
STM in all cases produced less isometric force than mdx stable STMs for direct twitch 
(P = 0.0077, df = 43, 2-Way ANOVA, Tukey’s post-hoc test), indirect twitch (P = 
0.0081, df = 44, 2-Way ANOVA, Tukey’s post-hoc test), direct tetanus (P = 0.0213, df = 
35, 2-Way ANOVA, Tukey’s post-hoc test), and indirect tetanus (P = 0.0222, df = 37, 2-
Way ANOVA, Tukey’s post-hoc test) stimulation groups (Figure 4.3).  
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Figure 4.3. Force recordings from EDL, SOL, and STM muscles. 
Direct (muscle evoked) and indirect (nerve evoked) isometric force from trunk and limb 
muscles. Twitch force was measured by delivering a single suprathreshold pulse to the 
nerve or muscle. Tetanic force was measure by delivering a 2 second train of stimuli at 
60 Hz. 2-Way ANOVA, Tukey’s post-hoc test. Asterisks denote significant differences 
(* P < 0.05, ** P < 0.01). Largely no changes in maximum isometric force were found 
between groups, except for geriatric mdx STM, which are significantly weaker than that 
of stable mdx.  
  
 
When the isometric force was normalized by body weight, a similar trend was 
noted (Figure 4.4). Normalized data is presented because changes in muscle force could 
be a product of a natural developmental increase in overall muscle size and not due to 
changes in neuromuscular transmission or the contractile apparatus of myofibers. While 
muscle weights and cross sections were not collected in this report, animal body mass 
before death was used as a surrogate for normalization. It should be noted that an 
allometric technique of scaling the normalized data was not used, which has been 
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suggested when normalizing muscle strength measurements to body mass (Folland et al., 
2008). Also, while increases in body mass as an approximation of increases in muscle 
mass could be accounted for, atrophy of muscles would be masked by the developmental 
increase in body size of mice. Decreases in normalized force could be overestimated in 
atrophied muscles.  
 
 
 
Figure 4.4. Normalized force recordings from EDL, SOL, and STM muscles. 
Direct (muscle evoked) and indirect (nerve evoked) isometric force from trunk and limb 
muscles. Twitch force was measured by delivering a single suprathreshold pulse to the 
nerve or muscle. Tetanic force was measure by delivering a 2 second train of stimuli at 
60 Hz. Force recordings were normalized to body weight. 2-Way ANOVA, Tukey’s 
post-hoc test. Asterisks denote significant differences (* P < 0.05, ** P < 0.01). Largely 
no changes in maximum isometric force were found between groups, except for geriatric 
mdx STM, which are significantly weaker than that of other groups. 
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 In fact, the normalization process showed that for the younger ages, force 
production between WT, mdx crisis, and mdx stable muscles were more similar than 
when not normalized, but there was a trend of increasing strength in mdx stable muscles. 
The STMs of geriatric mdx mice, however, again produced significantly less force than 
mdx stable, but in some cases, less than WT and mdx crisis, as well. Significant changes 
are detailed in Table 4.1. Thus, coincident with remodeling involving AChR 
granularization in geriatric mdx NMJs in the STM, significant reductions in contractile 
force were observed. The pathology of the disease in terms of muscular force production 
remained largely stable until senescence, indicating an interaction between age and the 
dystrophic state. Loss of force was perhaps due to changes in NMJ structure. 
 
 
Table 4-1. Normalized STM force recordings compared to mdx geriatric muscle. 
 WT vs mdx 
geriatric 
mdx crisis vs mdx 
geriatric 
mdx stable vs mdx 
geriatric 
Indirect Twitch n.s. P = 0.0383 
df = 44 
P = 0.0142 
df = 44 
Direct Twitch P = 0.0369 
df = 43 
P = 0.0032 
df = 43 
P = 0.0158 
df = 43 
Indirect Tetanus n.s. n.s. P = 0.0441 
df = 37 
Direct Tetanus n.s. P = 0.0084 
df = 35 
P = 0.0092 
df = 35 
Direct (muscle evoked) and indirect (nerve evoked) isometric force from STM muscles. 
Twitch force was measured by delivering a single suprathreshold pulse to the nerve or 
muscle. Tetanic force was measure by delivering a 2 second train of stimuli at 60 Hz. 
Force recordings were normalized to body weight. 2-Way ANOVA, Tukey’s post-hoc 
test. n = df +2. 
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 Seemingly, out of the muscles measured, the STM was the most affected during 
the progression of mdx muscular dystrophy in terms of muscle contractile properties and 
force production. It seems probable that this change in functionality was due to the 
ongoing myofiber degeneration and regeneration of the STM outlined in Section 3. The 
same constantly elevated degenerative process may not occur in the SOL and EDL, as it 
was not observed in the TA muscle. The TA underwent a true crisis period, of elevated 
myofiber damage followed by a mitigation period. Whether synaptic function is 
impacted by the ongoing degeneration and regeneration of the STM and/or the NMJ 
remodeling seen in geriatric mdx STM muscle remains unclear. 
 
4.3.1.3. NMJ remodeling has no negative effect of neuromuscular transmission 
Although direct electrophysiological recordings of neuromuscular synaptic transmission 
in mdx muscle were not conducted here, I assessed the NMJ performance by calculating 
an indirect-direct stimulation force ratio. For this calculation, indirect force 
measurements were divided by direct force measurements (Figure 4.4). Theoretically, if 
the synapse is functioning at 100% efficiency, the force elicited by direct and indirect 
methods should be roughly equivalent during supramaximal stimulation. A ratio of 1 
indicates an perfectly efficient synapse. This however is usually not observed even in 
healthy NMJs and indirect force was in most cases less than that of direct.  
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Figure 4.5. Functionality of mdx NMJs was not affected in geriatric mdx muscle.  
NMJ function in EDL, SOL, and STM muscles was determined by the ratio of indirect 
force/direct force. The closer the ratio was to 1, the higher the efficiency of 
neuromuscular transmission. Fatigue was measured as the decay in force following a 2-
second tetanic train of 60Hz. 2 -Way ANOVA, Tukey’s post-hoc test. Asterisks denote 
significant differences (* < 0.05). Largely no changes in maximum isometric force were 
found between groups, except for geriatric mdx STM, which were significantly weaker 
than that of stable mdx. 
 
 
No differences were found in geriatric mdx NMJ functionality when compared to 
WT or stable mdx stable (12 – 16 weeks) junctions. When the synaptic function during 
tetanic fatigue (measured as the ratio of maximum tetanic force retained at the end of the 
2 s train between direct and indirect stimulation) was used to assess the functionality of 
the STM synapse, the mdx stable and mdx geriatric muscles were more efficient than 
that of mdx crisis (mdx crisis vs stable: P = 0.0287, df = 33; mdx crisis vs mdx geriatric: 
P = 0.0064, df = 33. 2-Way ANOVA Tukey’s post-hoc test). The remodeling process 
described in the STM NMJs of mdx mice may constitute a homeostatic response to spare 
the synapse from dysfunction. Synaptic functionality became more resistant to fatigue in 
geriatric and stable mdx NMJs, thus maintaining substantial reliability of muscle 
contraction as the dystrophic motor system aged.  
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4.3.2. Geriatric mdx cardiac function 
 
4.3.2.1. M-Mode echocardiography 
Since reduced life span in mdx mice is thought to involve declining heart physiology 
with age, I assessed if cardiac function decreased in geriatric mdx mice. 
Echocardiography was performed in both conscious and unconscious WT and mdx mice 
to determine cardiac characteristics in both young adult and geriatric mdx mice, noting 
that evaluating conscious mice was more clinically relevant to humans. Additionally, 
anesthetics have been shown to effect cardiac ultrasound measurements (Chaves et al., 
2001; Roth et al., 2002). Unconscious M-Mode recordings from the parasternal, short 
axis window of the left ventricle indicated that several measures of geriatric mdx heart 
function were decreased, as compared to younger mdx animals (Figure 4.6). Fractional 
shortening (FS), a measurement of LV contractility, was decreased in geriatric mdx 
hearts compared to younger mdx hearts (Figure 4.6B). Furthermore, young mdx animals 
had larger FS measurements than young WT animals, suggesting that the LV of mdx 
animals had enhanced contractile function early in life that then declines significantly in 
old age. A similar event has been noted in GRMD animals and has been designated the 
hyperdynamic state (unpublished; Kornegay lab). 
Ejection fraction (EF), an assessment of volume of blood ejected from the LV 
during a single heartbeat, was also significantly reduced in the hearts of geriatric mdx 
animals, as compared to younger mdx animals (Figure 4.6A). Although not significant, 
measurements of the size of the LV (EDV: end diastolic volume, ESV: end systolic 
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volume, EDD: end diastolic diameter, ESD: end systolic diameter) largely track with an 
incidence of dilated cardiomyopathy between young and geriatric mdx hearts. That is, 
the chamber and overall mass of the LV of the mdx heart becomes larger in comparison 
to the other age groups and WT animals (Figure 4.6C). These findings suggest that mdx 
mice can avoid debilitating cardiomyopathy for much of their life, as seen in the EF and 
FS of young mdx. However, combined with geriatric influences on cardiac function, 
significant deficits in mdx heart physiology emerge when compared to younger mdx 
animals, perhaps one of the causes of for mortality in these older mice.  
 
  
118 
 
a 
 
Figure 4.6. M-Mode Echocardiography Measurements. 
A) Unconscious echocardiographic volumetric recordings. EDV - end diastolic volume; 
ESV - end systolic volume; SV - stroke volume; EF - ejection fraction. B) Unconscious 
echocardiographic diameter recordings. EDD - end diastolic diameter; ESV - end 
systolic diameter, FS – fractional shortening. C) Unconscious echocardiographic 
function and mass recordings. HR – heart rate; CO – cardiac output; LV Mass Corr – 
corrected left ventricular mass; LV Mass – left ventricular mass. One-Way ANOVA, 
Tukey’s post-hoc test. * P < 0.05. 
 
 
 Conscious M-mode measurements did not reveal significance patterns of 
cardiomyopathy, as compared to those detected in unconscious animals. In fact, the 
trends noted in the unconscious animal recordings of heart function were completely 
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absent (A-6). This was most apparent in the cardiac function parameters, namely EF and 
FS. The single instance of difference in conscious mice was found in LV mass between 
young WT and mdx animals, importantly representing a morphological consequence 
with a physiological impact that is evident only in certain recording paradigms, namely 
in unconscious mice. 
 
4.3.2.2. B-Mode echocardiography and strain analysis 
Speckle tracking has been used in human and animal populations to predict the onset of 
dilated cardiomyopathy. However, this has not been compared between mice in 
conscious and unconscious states, nor has it been performed at all in very old mdx mice. 
I hypothesized that both longitudinal and radial strain, measures of heart elasticity, 
would be decreased in young mdx animals, and would become further decreased in 
geriatric mdx animals. Differences in global longitudinal strain (GLS), however, were 
not found, as no statistically significant disparities were detected across any groups in 
either conscious or unconscious animals (Figure 4.7A and E). There was an intriguing 
trend for geriatric animals to display less strain than their younger counter parts. 
However, geriatric WT and mdx unconscious global GLS measurements were virtually 
indistinguishable from each other (Figure 4.7E. One-Way ANOVA, Tukey’s post-hot 
test, P > 0.9999).  
 A benefit of speckle tracking is that the LV can be divided into artificial sections 
and analysis performed on those specific sections. I artificially sectioned the ventricle 
into 6 parts (posterior base, posterior mid, posterior apex, anterior base, anterior mid, 
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anterior apex), and again analyzed the differences in peak strain between groups. 
Segmental strain was sub-divided into longitudinal and radial strain. Using this 
approach, segmental longitudinal strain assessment did indicate significant decreases in 
geriatric mdx animals. In unconscious geriatric mdx, longitudinal endocardial strain was 
significantly smaller than young WT animals in both basal segments (Figure 4.7C. 2-
Way ANOVA, Tukey’s post-hoc test, post base; P = 0.0016, ant base; P = 0.0073). In 
most segments, excluding posterior apex, geriatric mdx longitudinal strain trended lower 
than young mdx. Longitudinal strain measurements in conscious animals exhibited high 
variability and, therefore, the data was not of value for interpretation (A-7). Largely, 
though, geriatric mdx longitudinal strain was smaller than that detected in younger WT 
or mdx heart segments, supporting the general idea that very old age and dystrophy 
combine to compromise cardiac function in this dystrophic mouse model. 
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Figure 4.7. Echocardiograph Strain.  
A) Global longitudinal strain. B) Desynchrony in left ventricular contraction in terms of 
peak strain. C) Peak longitudinal strain of the 6 segments. D) Peak radial strain of the 6 
segments. E) Diagram of the segmental nature of the strain recordings of the left 
ventricle. A, B) 1-Way ANOVA. Tukey’s post-hoc test. C, D) 2-Way ANOVA. Tukey’s 
post-hoc test. Asterisk denote significance. * P < 0.05. ** < 0.01. 
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 In both unconscious and conscious measures of radial strain, no significant 
differences were noted between any groups (Figure 4.7D and A-7), although trends 
similar to those seen in longitudinal strain were present. Strain was in most cases, 
however, less in geriatric mdx that young WT animals. Using longitudinal strain in 
unconscious animals seems to be a better indicator of heart dysfunction.  
 In an effort to measure desynchrony of the contracting LV, the maximum time 
delay of opposing walls in terms of time of peak longitudinal strain was measured. This 
is essentially a measure of whether sections of the LV are contracting in concert with 
each other. No significant differences in maximum opposing wall delay was noted 
between groups (Figure 4.7B, F and A-7).  
 
4.4. Discussion 
The data presented in Section 4 suggest that dystrophic contractile tissue is able to 
function quite normally until very advanced ages, and even then, only certain skeletal 
muscles are affected. Dystrophic EDL and SOL had few discernable differences from 
WT muscles at any age, while geriatric mdx STM muscles showed decreased contraction 
force production. As mentioned some muscle groups are ravaged by the disease while 
others are largely spared, such as the extraocular muscles (Porter et al., 2003). To our 
knowledge, this is the first force recording investigation of mdx STM. Moreover, I 
observed that the hind limb muscles, EDL and SOL, were not affected by the disease in 
terms of force production. This contradicts the results of others, which noted a age 
dependent reduction in normalized isometric force production in mdx compared to WT 
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(Lynch et al., 2001). The STM, however, displayed decreases in force at geriatric ages 
compared to young mdx animals, but was not significantly changed from WT. There is a 
possibility that in order to adapt to the changes in muscle that occur in dystrophy, 
homeostatic events take place to reestablish synaptic function and force characteristics in 
dystrophic muscle. The homeostatic event may be a consequence of the NMJ remodeling 
itself. Nonetheless, this mechanism is insufficient to overcome the combined impacts of 
dystrophic disease and advanced age, and certainly has little to no effect on cardiac 
function.  
Changes to the mdx NMJ are progressive, at least in the STM muscle. The 
postsynaptic AChR aggregate became larger and more fragmented as the animal aged 
and muscle damage accumulated. Ultimately, at near the end of life stage in geriatric 
mice, the aggregate changed once again, becoming granular in appearance, possibly 
leading to dysfunctions in muscle contraction. I hypothesized that this would likely have 
a negative effect on the efficacy of the NMJ, but this was shown to be incorrect. 
Neuromuscular transmission (ratio of nerve evoked contractile force to direct muscle 
stimulation) in the STM of older mdx mice functioned equally compared to younger 
mdx and WT, and in some cases, was improved. This was evident when synaptic 
fatigability of the muscle during tetanus was investigated, where geriatric and stable mdx 
animals exhibited enhancements to neuromuscular transmission from those in the crisis 
period. NMJ remodeling has not fully taken place in all crisis mdx NMJs. It is not 
unlikely then that the remodeling process described in the STM of mdx mice, actually 
provides a means to increase the reliability of neuromuscular transmission. Ongoing 
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muscle fiber degeneration and regeneration eventually becomes pathological and the 
function of the muscle suffers as a result. In order to retain some functionality of the 
muscle, I suggest NMJ remodeling serves as a means to increase the response of the 
diseased tissue. This may only be during rigorous use, as twitch measurements of 
transmission efficacy in geriatric mice were not significantly changed from WT or 
younger animals. In terms of an animal’s behavior, STM muscles of geriatric mice 
produced less force overall than younger mdx or WT animals, and therefore any amount 
of fatigue due to failures in neurotransmission could be catastrophic. Alternatively, 
however, it is possible that this increase in contraction reliability displayed in these 
muscles could result in increased damage to the already compromised muscle. The 
fragile myofibers contraction during intense use, such as tetanus, would further injure 
them resulting in sustained bouts of muscle fiber degeneration, inflammation, and 
muscle fiber replacement with connective tissue. In this scenario, enhancement of 
neuromuscular transmission would actually be maladaptive. 
While the measurements above are categorized as measurements of reliability of 
neuromuscular transmission, the increased performance of the muscle during indirect 
stimulation could also be accounted for by myofiber type changes. This is a phenomenon 
that is known to occur in dystrophic muscle, as the proportion of type II fast twitch fibers 
decreases with an accompanying increase in the proportion of type I slow twitch fibers. 
In WT mice, the STM is made up of predominantly type II fast twitch muscle fibers. In 2 
month old mdx animals, the relative ratios of myofiber types has not changed to a great 
degree (Guido et al., 2010). In mdx limb muscles, fiber type shifting does not begin until 
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later ages, which may also be the case for the STM (Carnwath and Shotton, 1987). The 
STM displays elevated signs of atrophy and immune cell infiltration at later stages of the 
disease in mdx. (Lefaucheur et al., 1995). It is possible that in the geriatric mdx STM, 
fiber type switching also occurs during this time which could affect the force 
characteristics of the muscle. Other researchers have noted that neurotransmission of 
remodeled junctions due to aging in WT animals is no different than younger counter 
parts, and also state that neurotransmission in fragmented junctions may be enhanced 
(Willadt et al., 2016). However, fiber type switching was not assessed in this report, 
either.  
 The other organ severely affected during the progression of DMD is the heart. 
This is unsurprising, as cardiac tissue is also made up of contracting cells, 
cardiomyocytes, with dystrophin tethered to the intracellular side of the membrane. 
Cardiac tissue, unlike skeletal muscle, does not have the ability to regenerate damaged 
myofibers. Therefore, any damage that the heart incurs due to the dystrophin loss is 
irreversible. In boys with DMD, this results in dilated cardiomyopathy. The same is true 
of mdx mice, which I demonstrate here becomes evident in older ages and may 
contribute to the early death in these dystrophic animals. In unconscious mice, geriatric 
mdx hearts were discovered to function poorly in comparison to younger mdx animals, 
and indicated the generation of a dilated cardiomyopathy. It is possible that, as in 
skeletal muscle, a compensatory mechanism actually strengthens mdx hearts through 
much of the animal’s life, but ultimately begins to decline in dystrophic hearts at very 
old age. This has been termed the hyperdynamic state. 
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 Conscious measurement of heart function detected no differences between any 
groups using M-mode echocardiography. The stress caused by conscious recordings 
likely served as a confounder during these experiments. During conscious recordings, 
the heart rate of all groups was elevated from that of unconscious, thus complicating 
systolic function analyses. Moreover, at systole, the LV would close almost fully for all 
mouse groups, regardless of age of disease. This resulted in similar cardiac function 
measurements across groups. To assess cardiac function in mdx mice, I suggest 
echocardiography in anesthetized states as opposed to conscious. While, this procedure 
does not closely match that for how echocardiographs are obtained in clinic, the stress 
induced during conscious measurements in mice is not ideal. 
 Speckle tracking analysis has previously been used to illustrate early changes in 
heart elasticity during mdx disease progression. Multiple groups have recorded changes 
to strain as early as 3 to 9 months in mdx animals when compared to WT (Spurney et al., 
2011; Li et al., 2017; Zheng et al., 2017). Segmental analysis of the heart detected 
differences in region-specific strain between groups. The basal sections of the heart were 
the most affected, indicating that pathology is worse in these sections. This is 
corroborated by a recent report on GRMD cardiac function (Guo et al., 2019). Mdx LV 
have increased collagen and fibrotic tissue deposition beginning at early ages. It is 
possible that the loss of cardiomyocytes and replacement with non-contractile tissue 
occurs predominantly at these basal segments and result in less elasticity, indicated by 
changes to strain levels. No changes in radial strain nor desynchrony of development of 
peak longitudinal strain were noted here, in contradiction to other reports (Li et al., 
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2017). What can be appreciated, however, is that radial strain measurements were very 
low in the posterior base and mid sections as well as the anterior base of the LV for 
geriatric mdx. The use of speckle tracking to investigate mdx animals is still relatively 
novel. As such, trouble shooting and the development of reproducible protocols must be 
established quickly, and agreements in what measurements are most meaningful should 
be analyzed. I conclude that segmental longitudinal speckle tracking in unconscious 
animals may be the most robust method for analyzing changes in the function of mdx 
cardiac tissue, and the development of cardiomyopathies.  
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5. CONCLUSIONS 
 
5.1. The dystrophic neuromuscular junction 
This investigation further describes the mdx mouse and GRMD dog models of 
Duchenne muscular dystrophy. I conclude that the abnormal appearance of NMJs, 
characterized for decades in mdx, is also apparent in the canine model of DMD as a 
consequence of continued myofiber degeneration and regeneration. Likely, the 
morphological change in NMJs described here are conserved among all mammalian 
models of the disease, including humans. The dystrophic NMJ is remodeled in such a 
way that the AChR-rich endplate becomes fragmented, and in the case of very old 
junctions, granularized. These rearrangements are initiated by myofiber injury, and the 
innervating motor neuron must be present for remodeling to occur. This work has largely 
focused on the STM muscle, which may be an excellent muscular tissue for investigation 
of mdx dystrophic pathology. This neck muscle does not undergo a crisis period of 
increased muscle damage, as seen in limb muscles such as the TA, and muscle fiber 
degeneration and regeneration is elevated throughout the animal’s life span. The 
constant restructuring of the NMJ in dystrophic STMs may in fact protect the muscle 
from synaptic rundown during strenuous use.  
The conservation of NMJ remodeling in the mammalian models of DMD suggest 
this phenomena also occurs in humans, but no satisfactory investigation of a human 
DMD NMJ has been made. Therefore, it is possible that human DMD NMJs are distinct 
from mdx or GRMD.  Human NMJs in healthy muscle already have a fragmented 
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appearance when compared to that of rodents or dogs (Jones et al., 2017), so the 
remodeling process, if it occurs, may not parallel that noted in mdx or GRMD. Human 
tissue is especially difficult to obtain, especially in children and young adults, to our 
knowledge, a single investigation imaged DMD NMJs, albeit in cross section (Theroux 
et al., 2008). Thus, no information exists to assess in the detail presented above for the 
dystrophic mouse the morphology of these human junctions, especially in terms of 
fragmentation. In mdx and GRMD animals, I noted that not only did fragmentation of 
the postsynaptic AChR aggregate occur, but the area that synapse occupied was 
expanded during disease progression. These sorts of changes may also be occurring in 
the human NMJs and would not be appreciated in cross section as a large amount of the 
growth occurs along the length of the myofibers as opposed to its width.  
 Both the murine and canine models of dystrophy studied here involve the loss of 
the protein dystrophin in the muscle membrane. Therefore, it is reasonable to conclude 
that much of the NMJ remodeling that occur in these animals is due to disruption of 
DGC, and the resulting sarcolemmal instability. Even so, I cannot rule out the possibility 
that the remodeling process displayed in models of DMD is due to activity changes in 
other proteins, such as rapsyn or agrin, that are instrumental in regulating the 
developmental maturation of the NMJ. There is a reported decrease in the amount of 
MuSK (Pratt et al., 2015b) and a decrease in non-synaptic agrin expression in dystrophic 
mice (Eusebio et al., 2003). Mdx receptor endplates mature normally, from plaque to 
pretzel, until the onset of muscle damage in the mouse model, so developmental 
clustering must be taking place (Minatel et al., 2003). As the mdx animal never 
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expresses dystrophin during development, utrophin and the UGC provide the cues 
necessary for the initial maturation and remodeling process. In fact, the UGC is normally 
located at the synaptic area, while dystrophin is expressed throughout the muscle. The 
decreases in MuSK and agrin may prime the NMJ for remodeling in some fashion, as 
they are considered to be proteins integral to the aggregation and maintenance of 
receptor clusters at the NMJ. When agrin is removed from already mature NMJs, 
postsynaptic apparatus is disassembled, including the AChR aggregate (Samuel et al., 
2012). Perhaps the changes in mdx DI are an indicator of the lower levels of agrin which 
maintains this structure. Observationally, the changes seen in damaged muscles, which 
express dystrophin and normal levels of the clustering proteins, are not nearly as drastic 
as those of the mdx. So, deficiencies in the activities of these AChR clustering  proteins 
may indeed play a role in the restructuring process of dystrophy, although minor as 
compared to the degeneration of muscle fibers during dystrophic disease advancement.  
Alternatively, the retention of agrin in the basal lamina, and not its decreased 
expression, may dictate the remodeling process after myofiber injury. Following 
myofiber degeneration, agrin remains even as the basement membrane collapses. During 
regeneration, as the muscle expands, it will contact agrin and the membrane bound 
MuSK and LRP4 associated with the UGC will begin the receptor clustering process. 
Another theory is that new agrin may be released from neural varicosities of the newly 
rearranged motor axon as it grows in contact with the regenerated myofiber. The 
varicose nature of the regenerated nerve terminal and the location of new agrin in the 
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basal lamina would mediate AChR clustering into the fragmented morphology seen in 
dystrophy. 
 The extent to which neuron-to-muscle signaling or muscle-to-neuron signaling 
contribute to the remodeling of the NMJ during development has garnered significant 
study and debate for decades (McMahan, 1990; Kim and Burden, 2008; Yumoto et al., 
2012). Similarly, whether or not dystrophic remodeling of the NMJ has detrimental 
effects on neuromuscular transmission or the physiology of the dystrophic muscle is a 
contested subject. In mdx, indicators are present suggesting that synaptic function is 
perturbed (Nagel et al., 1990; Carlson and Roshek, 2001). The overall behavior of the 
mdx model does seem to be affected, but not much in terms of non-normalized isometric 
muscular force production (Lynch et al., 2001). It is not until the very last stages of the 
disease in mdx that any overt neuromuscular transmission deficits become appreciable, 
at least in our preparations, and then particularly in the STM, as compared to the other 
muscles studied. The aging process even in WT mice involves changes in NMJ 
morphology, again due to ongoing degeneration and regeneration of myofibers. These 
changes with aging, however, are mostly an increase in the number of AChR fragments 
(Willadt et al., 2016), and possibly junctional and receptor area (Cardasis and 
LaFontaine, 1987; Deschenes et al., 2011). In aged and remodeled junctions, there are no 
indications of failed neuromuscular transmission, and aged fragmented junctions may in 
fact be more reliable than younger synapses (Willadt et al., 2016). This agrees with 
studies that conclude that efficiencies of neuromuscular transmission is influenced by 
NMJ morphology. NMJs of different muscles have variable morphologies, which 
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correlate with the muscle on which they reside. Some NMJs are larger, some are smaller, 
and some are more fragmented than others (Jones et al., 2016). Although the 
morphological aspects of NMJs may be variable, their ultimate function is consistent. 
Evoked EPPs from populations of NMJs on different muscles, with distinct 
morphological attributes, were on average indistinguishable from each other. However, 
when quantal release was investigated, it was noted that the morphology of the NMJ 
dictated synaptic release characteristics. Smaller NMJs had larger MEPPs that were less 
frequent, and evoked release events had a lower quantal content.  
 
5.2. Functional properties of the dystrophic neuromuscular junction 
Variation in NMJ morphology is striking across animal species, but these differences in 
form do not dramatically dictate synaptic function. Still, at the vertebrate NMJ, some 
aspects of its structure assure that excitation of the muscle is much greater than that 
needed for repeated, forceful contraction. This ability to remain effective under broad 
physiological conditions due to over excitation of the muscle fiber is termed the NMJ’s 
safety factor, and postsynaptic folding associated with the muscle endplate is thought to 
be central to this phenomenon (Martin, 1994; Wood and Slater, 1997). Species-specific 
attributes of the NMJ correspond well to changes seen in the morphology of the 
dystrophic junction. Others and I report on the fragmentation of the receptor aggregate 
and describe an expansion of the endplate as well (Lyons and Slater, 1991; Pratt et al., 
2013; Haddix et al., 2018). Mdx mice also display a reduction in the length of 
postsynaptic membrane invaginations, but no decreases in the amount of AChR sites per 
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NMJ (Lyons and Slater, 1991). This suggests that while the NMJ structure drastically 
changes during the dystrophic disease advancement, homeostatic changes are perhaps 
being made to the NMJ to preserve neuromuscular function. These linked changes in 
NMJ morphology and function would be highly adaptive. The loss of junctional folds 
following the regeneration of the NMJ might decrease the safety factor of synaptic 
transmission and excitation-contraction coupling. To compensate, it is plausible that the 
synapse expands in order to release more, and more effective, quanta of transmitter upon 
terminal excitation. However, some previous investigations indicate quantal content is 
not increased in young mdx animals (Nagel et al., 1990; Lyons and Slater, 1991), while 
other demonstrate decreases in MEPP amplitude and increases in quantal content 
(Carlson and Roshek, 2001). Our data also suggests that endplate size and receptor area 
does not significantly grow until later in life, which may explain the discrepancies in 
mdx synaptic function between ours and others interpretations suggested previously. 
Indeed quantal content does increase at 37 weeks of age (Nagel et al., 1990), but these 
researchers also noted an increase in endplate size at early time points without 
corresponding neuromuscular transmission changes.  
There does seem to be some amount of conflict and variance in the data 
generated from different labs on the neuromuscular transmission properties in mdx mice. 
Although there is general agreement that the morphology of the junction is rearranged in 
dystrophy, it remains poorly understood if, or how, these changes result in quantal 
acetylcholine release changes. Some of these discrepancies likely arise from the different 
muscles studied (diaphragm versus ETA, for example) and the different time points in 
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disease progression analyzed. Here, I demonstrate that the remodeling process of the 
NMJ in dystrophy in both dogs and mice is progressive, following the advancement of 
the disease. I suggest that a certain amount of remodeling must take place before 
significant changes to quantal release might be observed. As evidence to this point, I 
show that neuromuscular efficiency, as the ratio between muscle evoked and motor 
neuron evoked fatigue during tetanic stimulation, was increased in older mdx STMs, as 
compared to the normal efficiency at crisis period NMJs of young mdx mice (Section 4). 
Increased safety factors are not necessary for non-taxing contractions such as twitch, but 
they are for highly rigorous, high frequency behaviors. During tetanic stimulation, 
muscle fatigability was equal between both direct and indirectly stimulated highly 
remodeled NMJs. While not significant, there is a 50% increase in the density of 
synaptic vesicles at mdx terminals (Nagel et al., 1990), which could account for the 
protection against tetanic fatigue seen in geriatric mdx STM NMJs, even with highly 
fragmented, sometimes disintegrating, endplate structure. As such, the pool of vesicles 
available to respond to a nerve impulse may not run down, as there are simply more than 
enough in a releasable state or in reserve. This would absolutely be necessary if the 
receptor response to acetychloline was diminished (smaller MEPP) and the junctional 
folds were lost. Therefore, a homeostatic increase in quantal content (i.e., the number of 
vesicles involved per motor neuron action potential) would likely be needed to illicit the 
same, efficacious response in a geriatric mdx muscle. To elucidate what exactly protects 
geriatric mdx junctions from dysfunction in the STM, future single fiber 
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electrophysiology, with corresponding ultrastructural analysis of the NMJ, would be 
very beneficial.  
It should be noted that the investigations here of progressive remodeling were 
limited to the STM muscle, and it is entirely possible that muscles that experience the 
crisis period, or even those that do not, during disease progression may not remodel the 
NMJ in quite the same way, as suggested by the decrease in receptor replacement noted 
in mdx TA after 5 weeks. Although the force generation characteristics of STM, SOL, 
and EDL were studied, no effort was made to correlate synaptic structure to 
electrophysiological properties of the NMJ. It should also be noted that no similar 
neuromuscular physiology had been conducted on GRMD dog muscles, and very little is 
known in DMD boys. Therefore, a complete picture of the functional properties of the 
dystrophic neuromuscular junction remains to be elucidated.   
As mentioned earlier, the normal human NMJ, while relatively smaller than that 
of a rodent, has a fragmented appearance. While not to the degree of an mdx mouse or 
GRMD dog, the receptor clusters are arranged in discrete islands, with terminal 
varicosities juxtaposed to the receptor aggregates (Oda, 1984; Slater et al., 1992). 
Furthermore, the vesicle release machinery is organized in a distinctly different fashion 
from that of rodent terminal boutons (Jones et al., 2017). The total area of active zone 
puncta, as determined by SNAP25 labeling, a presynaptic protein involved in transmitter 
secretion, is similar between mice and humans, but the density and spatial organization 
of those puncta are different between the two. As the human NMJs are smaller, the 
density of the labeled puncta is higher, but also located at the periphery of the synaptic 
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boutons in a ring like manner, rather than the seemingly random arrangement within the 
ribbons of the mouse junction. Whether this is the same for the mdx puncta is not 
known.  
There seem to be two possibilities for how the mdx active zones are organized 
over the islands of AChR aggregation. 1) The synaptic vesicle machinery is rearranged 
in the mdx boutons to that similar to humans or 2) the mdx presynaptic apparatus 
remains dispersed, similar to that of WT mice. The latter would require a different 
structure from the peripheral ring architecture observed in human terminals. The first 
possibility is supported by our observational data from both dystrophic mice and dogs. 
When labeled for neurofilament and SV2, a protein found on synaptic vesicles, a ring of 
fluorescence is seen within the terminal boutons, similar to SNAP25 labeling seen at 
human junctions. This ring is likely SV2, as neurofilament does not in normal 
circumstances extend into the terminal area (observational). The high density of synaptic 
vesicles in the ring formation is indicative of active zone locational changes and support 
a homeostatic rearrangement of the secretory machinery at remodeled dystrophic 
junctions. The second possibility is supported by two pieces of evidence, one 
morphological and one based on electrophysiology. Human NMJs have a much more 
complex secondary folding of the postsynaptic membrane, in contrast to mice. This 
greater complexity of the endplate corresponds to changes on the presynaptic side of the 
human junction, where the density of active zones is increased, and their distribution 
changed compared to mouse junction, as mentioned above (Jones et al., 2017). Even 
more different are the junctional folds of mdx synapses, which are not nearly as 
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numerous or deep as WT NMJs, suggesting again through correlation that active zones 
might also differ between dystrophic and healthy synapses, although this has not been 
reported in the limited mdx NMJ ultrastructure investigations, which tend to focus only 
on junctional folds. Additionally, human quantal content is much lower than that of 
mice, and mdx quantal content is even higher than that of WT mice. Again, the much 
greater transmitter release in mdx may be explained by the increased size of the endplate 
and possible relocalization of active zones. However, as indicated by our force 
recordings, the extensive structural changes that occur during the remodeling of the mdx 
NMJ do not result in result in significant decreases in synaptic function. I conclude that 
as yet unknown changes in synaptic physiology are homeostatic in nature and 
compensate for lost of NMJ structural integrity, while maintaining efficiency of 
neuromuscular transmission and ensuring the reliability of skeletal muscle contractile 
function.  
To fully appreciate potential changes to presynaptic machinery and vesicle fusion 
sites, labeling experiment of active zone proteins would be instructive. Investigating the 
distribution of SNAP25, piccolo, bassoon, or other vesicle proteins involved in vesicle 
fusion with super resolution microscopy, combined with new tissue clearing approaches 
(Williams et al., 2019), will allow researchers to determine the extent of active zone and 
release apparatus rearrangement at mdx NMJs. Such an approach would reveal hot spots 
of transmitter release and any unequal distribution of the same across NMJ fragments. It 
has been demonstrated using synaptoPHlorin (an optical indicator of neurotransmitter 
release),  that in WT murine NMJs not all areas of the endplate have equal amounts of 
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synaptic vesicle fusion (Wyatt and Balice-Gordon, 2008). Variability in presynaptic-
postsynaptic transmission machinery matching, I predict, would not only exist, but be 
greater in the highly fragmented NMJs of older and geriatric mdx mice and restricted to 
only certain “islands”. Although not addressed here, the presynaptic function of the mdx 
model would be of special interest for future studies, particularly in the older dystrophic 
animals as our indirect measures of synaptic reliability was increased in highly 
remodeled junctions. 
As mentioned above, changes in neuromuscular transmission efficiency and 
force generation were only observed at older ages in mdx mice, and only in the STM 
muscle. In these muscles, a resiliency against fatigue during tetanic stimulation was 
seen. This resiliency in function was surprising, especially in geriatric mdx NMJs which 
were have two distinct morphologies: a highly fragmented form, and an even less 
structured form that I termed granular or disintegrated, and was unlikely to be 
physiologically active. Initial time course studies of NMJ remodeling in mdx mice 
suggested that dystrophic junctions continue to grow larger with disease progression, but 
here I report that this did not hold true. However, it should be noted that junctional size 
measurements from granular junctions were included in the analysis, which may have 
skewed the data toward smaller junction sizes.  Frequently, small granular junctions 
were observed adjacent to fragmented ones. Granular junctions were usually innervated, 
but whether that innervation was full or partial was difficult to assess and therefore not 
measured. 
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 Regardless, I believe that remodeled junctions (either fragmented to granular) 
may be responsible for the increase efficiency in the geriatric mdx STM. In order to 
increase synaptic strength and reliability at junctions on the verge of disintegration, there 
would likely need to be a concomitant reorganization of active zones and the 
corresponding postsynaptic junctional sarcolemma. Since the reappearance of junctional 
folds in geriatric mdx animals is unlikely, I conclude that the presynaptic apparatus or 
properties of receptors themselves are the likely culprits contributing to surprising 
function of remodeled NMJs. Ultimately, direct assessments of neuromuscular 
transmission and the synaptic machinery will reveal the nature of NMJ strengthening of 
the granular and fragmented remodeled synapse in mdx muscle.  
Another possibility there is significant myofiber loss in the geriatric mdx 
animals. The NMJs investigated above may reside on myofibers that were resistant to 
damage or had characteristics that increased their regenerative capacity. Synapses that 
were on inefficient myofibers could be selectively lost. The incidence of myofiber loss 
in these end-stage mdx animals is currently being investigated by the Thompson Lab 
(Ryan Massopust, unpublished data). 
 
5.3. Dystrophic cardiomyopathy 
The other majorly affected body system in DMD, apart from the skeletal muscle, 
is the cardiovascular system. It is well documented that afflicted men develop 
cardiomyopathies in the later stages of this dystrophic disease. Echo- and 
electrocardiography reveal that the pathology progresses from pre-clinical (or non-
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symptomatic), to hypertrophic cardiomyopathy, and finally to dilated cardiomyopathy 
(Nigro et al., 1990). Hypertrophic cardiomyopathy is ultimately defined as a change in 
the ratio between the septum width and the LV free wall width. Dilated cardiomyopathy 
is characterized as an increase in the size of the LV, and changes to the contractility of 
the chamber usually present as decreases in EF).  
Dystrophic canines also develop a cardiomyopathy associated with the loss of 
dystrophin from cardiomyocytes (Valentine et al., 1989; Moise et al., 1991; Yugeta et 
al., 2006). The GRMD cardiomyopathy proceeds much like that of DMD boys, at least 
in terms of microscopic pathology changes. A pre-pathological stage advances to an 
intermediate stage at about 1 year. At this point, the GRMD hearts display fibrotic 
deposition and signs of cardiomyocyte necrosis, predominantly in the epimyocardium of 
the LV. At 6 years, the cardiomyopathy becomes pathological, in that decreases in LV 
movement are noted via echocardiography. This corresponds to increased fibrotic 
deposition, fatty tissue disposition, and more of the heart being subjected to contractile 
tissue removal. Additionally, as seen in myofibers, there is an increase in the variation in 
the myocardial cell size (Valentine et al., 1989). This suggests that an event similar to 
that in muscles is occurring in GRMD cardiac tissue. Specifically, there is significant 
cellular damage due to contraction forces generated in the absence of cardiac dystrophin. 
As mentioned before, cardiac tissue does not have resident stem cells like skeletal 
muscle to respond to cellular necrosis. Tissue lost due to damage in the heart is 
irreplaceable.  
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Echocardiography and more advanced imaging techniques of GRMD corroborate 
both previous investigations of dystrophic canine hearts, and our data in mdx hearts 
(Guo et al., 2019). Circumferential strain, measured with speckle tracking, was shown to 
be a sensitive measure for the development of cardiomyopathy in dogs. This is similar to 
our finding that segmental longitudinal strain could discover cardiac dysfunction in 
geriatric mdx left ventricles as compared to young WT. Additionally, late gadolinium 
enhancement in cardiac magnetic resonance indicated that the basal segments of left 
ventricle were the most majorly affected areas in GRMD. This again agrees with our 
data in mdx that shows that anterior and posterior basal segments of the LV are affected 
in geriatric mdx hearts.  
Like dystrophic dogs, the mdx mouse undergoes similar cardiomyopathic events 
to DMD (Bridges, 1986). The development of the murine cardiomyopathy seems 
restricted mostly to the LV as seen in DMD, and the canine model. A similar progression 
from a mild to more severe dilated cardiomyopathy is also noted. Fibrosis due to cellular 
damage is evident in the later stages, and this leads to dilated cardiomyopathy, in which 
heart contractility is compromised (Quinlan et al., 2004; van Putten et al., 2014). As 
opposed to the canine model, there is always an increased macrophagic infiltration in 
mdx hearts (Van Erp et al., 2010). Perhaps the pathological advancement of the two 
diseases is dissimilar. Evan’s blue dye uptake, however, is constantly elevated in the 
murine model, indicating a continuous level of membrane damage occurs, much like that 
observed in the mdx STM.  
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The systolic function of mdx hearts as assessed by traditional echocardiography, 
largely does not show functional deficits until the later stages of the disease, and are not 
distinguishable from WT before 6 months of age (Quinlan et al., 2004; Au et al., 2011). 
Some researchers, however, have noted a very different pattern of cardiac involvement. 
In fact, it has been noted that early in life (2 months) the mdx heart contracts more than 
that of WT (van Putten et al., 2014). This is similar to our echocardiographic data in the 
young mdx mice. Where our results begin to differ from the reports of others is in the 
geriatric ages of mdx mice. Although I did record a decrease in the function of the 
geriatric versus younger mdx hearts, EF and SV were indistinguishable from that of WT 
animals. It is possible that just as with the NMJ, mdx cardiac physiology may involve a 
homeostatic regulation. The increased contractility of the heart may be in response to an 
overall instability of the cardiomyocytes, and an early functional hypertrophic event of 
the myocardium. Although few studies have investigated the heart functionality at 
geriatric ages, those that have noted a significant decreases in heart function compared to 
WT (Bostick et al., 2009; Bostick et al., 2010). In our geriatric mdx analyses, significant 
decrease in cardiac function (EF and FS) were found only when comparing geriatric mdx 
hearts to young mdx hearts. These patterns did not exist in the conscious mice, likely due 
to the stress caused by the recording procedures. 
It is possible that the mdx heart must contract at a greater intensity to function the 
same as the WT heart, perhaps due to metabolic or vascular changes in the mdx mouse. 
In this case, the decrease in EF and FS in the geriatric mdx animals as compared to 
young mdx, may indicate a true pathological event and a dilated cardiomyopathy as 
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noted by increased in LV mass. While I did not investigate the actual morphology or 
fibrotic deposition within dystrophic hearts, contractile heart tissue begins to be replaced 
by connective and fibrotic tissue early in life (Van Erp et al., 2010).  
It should be noted that the ages of the geriatric mdx studied here are all above 19 
months. It was not recorded, but there was a noticeable dropout of animals within our 
colony, as has been seen in natural life history assessments of mdx populations 
(Chamberlain et al., 2007). It is entirely possible that the small geriatric sample from our 
colony represents dystrophic individuals who are not as affected by the disease state or 
are especially capable of mounting homeostatic mechanisms to compensate for disease 
progression. Here, our younger sample would be more representative of the total 
population, while the geriatric animals might not display the same progression of heart 
involvement. As echocardiography is a completely non-invasive technique, it would be 
beneficial to perform a longitudinal study from 3 months to the end stage of the disease, 
rather than the typical study endpoint at 12 months of age, which is only about midlife 
for mdx animals.  
 
5.4. Summary 
Overall, our results give a refined view of neuromuscular and cardiac changes caused by 
dystrophy in dog and mouse models. In summary, I found: 
1) The morphology of mdx NMJs is vastly different than WT and changes to 
the dystrophic NMJ are progressive and advance with the disease state in 
the STM. 
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2) GRMD NMJs display similar changes to those of mdx, and these 
aberrations are likely conserved in all mammalian dystrophic states, 
including DMD. 
3) The dystrophic STM does not undergo an early life crisis period of 
muscle fiber injury, like that seen in the TA of mdx mice. Myofiber 
degeneration and regeneration are constantly elevated in the dystrophic 
STM. 
4) NMJ remodeling in mdx is initiated by myofiber damage near the 
endplate region of the muscle, and the motor axon terminal must be 
present for remodeling to occur in murine dystrophy. 
5) Remodeled junctions in mdx are not deficient in neuromuscular 
transmission, and at geriatric ages may actually serve to increase response 
to synaptic stimuli.  
6) The NMJ is not a good target for treatment to ameliorate DMD pathology 
and disease progression.  
7) On the other hand, morphological changes to the NMJ are excellent 
biomarkers for disease severity and progression, and the STM, like the 
diaphragm offers a model muscle for investigation of the disease.  
8) The cardiac function of mdx mice is best assessed in unconscious mice. 
9) Geriatric mdx cardiac function is not changed from that of WT, although 
young mdx mice display increased cardiac contractility. Geriatric mdx 
heart function is decreased as compared to young mdx. 
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10) Strain analysis, via speckle tracking, indicates that the basal segments of 
the left ventricle are the most affected regions of the heart of geriatric 
mdx mice, but defects are only appreciable at geriatric ages. 
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APPENDIX A 
A-1. 3D rotation of P66 mdx NMJ.	 
https://www.dropbox.com/sh/0qwmxx48u6kxbsn/AABtEe-
sNjBvzc6ZdKKTEXo4a?dl=0 
URL link above to 3D maximum intensity projection of confocal stack. 0.5 µm gap 
between collection slices interpolated via ImageJ 3D Projection tool. BTX-1 
pseudocolored red. BTX-2 pseudo colored green. DAPI nuclear label pseudocolored 
gray. Note the occurrence of a  central chain of nuclei running within the myofiber 
directly under the dynamic, fragmented junction  
 
A-2. Significant differences in NMJ categorization following in vivo two- color BTX 
experiments (P38 WT and mdx). 
 
Comparisons within genotypes. 2-Way ANOVA with Bonferroni post-hoc test. Red 
boxes indicate redundancy. Black boxes indicate comparisons of the same categories. * 
P < 0.05. ** P < 0.01. *** P < 0.001.  
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A-3. Significant differences in NMJ categorization following in vivo two- color BTX 
experiments (P38 WT myofiber cut damage at the endplate and IC).  
 
Comparisons within groups. 2-Way ANOVA with Bonferroni post-hoc test. Red boxes 
indicate redundancy. Black boxes indicate comparisons of the same categories. * P < 
0.05. ** P < 0.01. *** P < 0.001.  
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A-4. Significant differences in NMJ categorization following in vivo two- color BTX 
experiments (P38 mdx myofiber crush damage and IC).  
 
Comparisons within groups. 2-Way ANOVA with Bonferroni post-hoc test. Red boxes 
indicate redundancy. Black boxes indicate comparisons of the same categories. * P < 
0.05. ** P < 0.01. *** P < 0.001.  
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A-5. Significant differences in NMJ categorization following in vivo two-color BTX 
experiments (P38 mdx denervation and IC).  
 
Comparisons within groups. 2-Way ANOVA with Bonferroni post-hoc test. Red boxes 
indicate redundancy. Black boxes indicate comparisons of the same categories. * P < 
0.05. ** P < 0.01. *** P < 0.001.  
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A-6. M-Mode Echocardiography Measurements. 
 
 
A) Conscious echocardiographic volumetric recordings. EDV - end diastolic volume; 
ESV - end systolic volume; SV - stroke volume; EF - ejection fraction. B) Conscious 
echocardiographic diameter recordings. EDD - end diastolic diameter; ESV - end 
systolic diameter, FS – fractional shortening. C) Conscious echocardiographic function 
and mass recordings. HR – heart rate; CO – cardiac output; LV Mass Corr – corrected 
left ventricular mass; LV Mass – left ventricular mass. 1-Way ANOVA, Tukey’s post-
hoc test. * P < 0.05. 
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A-7. Conscious cardiac strain analysis.  
 
Speckle tracking measurements from conscious WT and mdx mice. A) Global 
longitudinal strain. B) Desynchrony in left ventricular contraction in terms of peak 
strain. C) Peak longitudinal strain of the 6 segments. D) Peak radial strain of the 6 
segments. A, B) 1-Way ANOVA. Tukey’s post-hoc test. C, D) 2-Way ANOVA. 
Tukey’s post-hoc test. Asterisk denote significance. * P < 0.05. ** < 0.01. 
 
